丙烯酰胺

IARC第2A组 — 可能对人类致癌
CAS: 79-06-1 | IARC来源
EU SVHCMolGod评分:主要

4,99 €

化学品 Akrylamid (CAS 79-06-1)。完整百科卡片 — 分类、性质和安全数据 — 如下。

🔒 系统已阻止销售

Akryloamid · 限制(REACH 附件 XVII)

附件 XVII · 第 67 条第 1 款 · REACH 法规(EC)第 1907/2006 号

此拦截依据法规基准自动施加,而非运营者的决定。 法律依据 ↗

MolGod_SDSCARD_1
REACH 2020/878
v1 · 16.07.2026
🧬 3D分子可视化器
正在加载分子...
3D模型Acrylamide,CAS 79-06-1,分子式C3H5NO, 摩尔质量 71.08 g/mol
化学概述: AcrylamideMolGod_OVERVIEW_1
分子式C3H5NO
分子量71.08 g/mol
熔点84.5 °C
密度1.13 g/cm³
LogP(亲脂性)-0.7
IUPAC名称prop-2-enamide
SMILESC=CC(=O)N
InChIKeyHRPVXLWXLXDGHG-UHFFFAOYSA-N

同义词: ACRYLAMIDE · 79-06-1 · 2-Propenamide · prop-2-enamide · Propenamide

数据来源: PubChem (NLM/NIH)
最后更新: 2026-11-10

科学研究

[1]OpenAlex2021
Jong‐Su Park, Palas Samanta, Sangwoo Lee et al.. (2021). "Developmental and Neurotoxicity of Acrylamide to Zebrafish". International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22073518
[2]OpenAlex2018
Melissa Faria, Tamar Ziv, Cristian Gómez‐Canela et al.. (2018). "Acrylamide acute neurotoxicity in adult zebrafish". Scientific Reports. https://doi.org/10.1038/s41598-018-26343-2
[3]OpenAlex2016
N. Muttucumaru, Stephen J. Powers, J. Stephen Elmore et al.. (2016). "Acrylamide-forming potential of potatoes grown at different locations, and the ratio of free asparagine to reducing sugars at whic
[4]OpenAlex2012
Toxicology and carcinogenesis studies of acrylamide (CASRN 79-06-1) in F344/N rats and B6C3F1 mice (feed and drinking water…
(2012). "Toxicology and carcinogenesis studies of acrylamide (CASRN 79-06-1) in F344/N rats and B6C3F1 mice (feed and drinking water studies).". PubMed.
[5]OpenAlex2011
Claudio Pelucchi, Carlo La Vecchia, Cristina Bosetti et al.. (2011). "Exposure to acrylamide and human cancer—a review and meta-analysis of epidemiologic studies". Annals of Oncology. https://doi.org/
[6]OpenAlex2011
European Food Safety Authority. (2011). "Results on acrylamide levels in food from monitoring years 2007–2009 and Exposure assessment". EFSA Journal. https://doi.org/10.2903/j.efsa.2011.2133
[7]OpenAlex2009
Burhan I. Ghanayem, Re Bai, Grace E. Kissling et al.. (2009). "Diet-Induced Obesity in Male Mice Is Associated with Reduced Fertility and Potentiation of Acrylamide-Induced Reproductive Toxicity1". Bi
[8]OpenAlex2008
Sean M. Hays, Lesa L. Aylward. (2008). "Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1)". Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2008.05.0
📚 科学参考文献(芝加哥作者-日期格式) 11 refs · 3 baz

MOLEKUŁA 按CAS号参考文献(实时来自13+数据库)

来源: db:openalex (8) · db:core (3)

  1. db:openalex Jong‐Su Park, Palas Samanta, Sangwoo Lee et al.. (2021). "Developmental and Neurotoxicity of Acrylamide to Zebrafish". International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22073518 →
  2. db:openalex Melissa Faria, Tamar Ziv, Cristian Gómez‐Canela et al.. (2018). "Acrylamide acute neurotoxicity in adult zebrafish". Scientific Reports. https://doi.org/10.1038/s41598-018-26343-2 →
  3. db:openalex N. Muttucumaru, Stephen J. Powers, J. Stephen Elmore et al.. (2016). "Acrylamide-forming potential of potatoes grown at different locations, and the ratio of free asparagine to reducing sugars at which free asparagine becomes a limiting factor for acrylamide formation". Food Chemistry. https://doi.org/10.1016/j.foodchem.2016.09.199 →
  4. db:openalex (2012). "Toxicology and carcinogenesis studies of acrylamide (CASRN 79-06-1) in F344/N rats and B6C3F1 mice (feed and drinking water studies).". PubMed.
  5. db:openalex Claudio Pelucchi, Carlo La Vecchia, Cristina Bosetti et al.. (2011). "Exposure to acrylamide and human cancer—a review and meta-analysis of epidemiologic studies". Annals of Oncology. https://doi.org/10.1093/annonc/mdq610 →
  6. db:openalex European Food Safety Authority. (2011). "Results on acrylamide levels in food from monitoring years 2007–2009 and Exposure assessment". EFSA Journal. https://doi.org/10.2903/j.efsa.2011.2133 →
  7. db:openalex Burhan I. Ghanayem, Re Bai, Grace E. Kissling et al.. (2009). "Diet-Induced Obesity in Male Mice Is Associated with Reduced Fertility and Potentiation of Acrylamide-Induced Reproductive Toxicity1". Biology of Reproduction. https://doi.org/10.1095/biolreprod.109.078915 →
  8. db:openalex Sean M. Hays, Lesa L. Aylward. (2008). "Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1)". Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2008.05.010 →
  9. db:core Skott, A., Hofmann, A., Sorgel, F. et al.. (2002). "Acrylamide: Increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans". https://doi.org/10.1159/000069715 →
  10. db:core Lawrence, Justin R., O\u27Neill, Feidhlim T., O'Neill, Feidhlim T. et al.. (2001). "Thickness variation of self-processing acrylamide-based photopolymer and reflection holography". https://doi.org/10.1117/1.1353801 →
  11. db:core (0). "NIOSH skin notation profile : acrylamide [CAS No. 79-06-1]".
📊 物理化学性质

快速参考

化学式: C3H5NO
分子量: 71.08 g/mol
CAS号: 79-06-1
外观: Flake-like crystals from benzene
气味: Odorless
气味: Odorless

详细性质

属性 值 单位 条件 来源
密度(ρ) 1.1300 g/cm³ 20 °C (68 °F)
熔点(mp) 84.50 °C (184.1 °F) 1 atm
闪点 137.80 °C (280 °F) closed cup
水溶性 soluble (≥999) g/L 25 °C (77 °F)
🔬 高级属性

化学标识符

SMILES: C=CC(=O)N

数据来源: PubChem, NIST Chemistry WebBook, CRC Handbook of Chemistry and Physics (103rd ed.)

最后更新: 2026-06-30

物质监管状态
该化合物: 出现在SVHC候选清单中(REACH第59条). 清单: EU/SVHC. 监管信息——不限制在本店购买。
🧮 化学计量计算器MolGod_STOICH_1
🔍 外部标识符MolGod_EXTID_1
13 / 16个ID系统81%
数据库标识符操作
CAS Registry Number79-06-1打开 →
PubChem CID6579打开 →
InChIKeyHRPVXLWXLXDGHG-UHFFFAOYSA-N打开 →
InChIInChI=1S/C3H5NO/c1-2-3(4)5/h2H,1H2,(H2,4,5)
SMILESC=CC(=O)N
EC Number201-173-7打开 →
KEGG CompoundC01659打开 →
HMDBHMDB0004296打开 →
ChemSpider6331打开 →
MeSH UID (NLM)D020106打开 →
UNII (FDA)20R035KLCI打开 →
NSC Number (NCI)7785打开 →
WikiData QIDQ342939打开 →

来源:PubChem (NIH)、Wikidata SPARQL、KEGG、ChEMBL (EBI)、CompTox CTX (EPA)。

📡 光谱学 — CAS 79-06-1MolGod_SPECHUB_MAIN
📊 光谱数据库 — 内联数据 9 来源 MolGod_SPECDB_2

光谱按需从9个来源获取。每个光谱都存储在我们的数据库中 — 下次打开时无需向外部API发出请求。无需搜索即可为每个光谱下载JCAMP-DX / CSV / PNG。

IR IR (Infrared) — NIST WebBook
Public domain (US Federal)
▶ 点击加载光谱
🔗 来源
— 点
📚 NIST Chemistry WebBook, SRD 69
MS (NIST) Mass Spectrum (EI) — NIST WebBook
Public domain (US Federal)
▶ 点击加载光谱
🔗 来源
— 点
📚 NIST Standard Reference Database 1A
UV-Vis UV/Visible Absorption — NIST WebBook
Public domain (US Federal)
▶ 点击加载光谱
🔗 来源
— 点
📚 NIST Chemistry WebBook, SRD 69
¹H NMR NMR (¹H, ¹³C) — NMRShiftDB
CC-BY-SA 4.0
▶ 点击加载光谱
🔗 来源
— 点
📚 Steinbeck C et al. (2003) J. Chem. Inf. Comput. Sci. 43(1):10–16 DOI: 10.1021/ci025588g
MS (MoNA) MoNA — MassBank of North America
CC-BY 4.0
▶ 点击加载光谱
🔗 来源
— 点
📚 MassBank of North America (UC Davis) DOI: 10.1002/jms.1777
IR/NMR/MS (SDBS) SDBS — Spectral Database for Organic Compounds (Japan AIST)
Free for non-commercial

参考来源 — 无公共API。在外部数据库中打开:

🔗 IR/NMR/MS (SDBS) →
📚 SDBSWeb: https://sdbs.db.aist.go.jp (AIST, Japan)
JP Monograph Japanese Pharmacopoeia — Monographs
Reference only

参考来源 — 无公共API。在外部数据库中打开:

🔗 JP Monograph →
📚 Japanese Pharmacopoeia 18th Edition (2021)
WHO INN WHO — International Nonproprietary Names
WHO Model Lists (free)

参考来源 — 无公共API。在外部数据库中打开:

🔗 WHO INN →
📚 WHO INN Programme
DOAJ DOAJ — Directory of Open Access Journals
OA journal index (mixed)

参考来源 — 无公共API。在外部数据库中打开:

🔗 DOAJ →
📚 DOAJ — doaj.org
🔬 交互式光谱(实时 — NIST / MoNA / NMRShiftDB / SDBS) (2)

数据从多个来源实时获取(优先级链)。每个光谱下可下载JCAMP-DX / CSV / PNG。 ⓘ 单一来源 ★★☆☆☆

IR — 傅里叶变换红外光谱

正在加载 IR — 傅里叶变换红外光谱…

MS — 质谱(EI 70eV)

正在加载 MS — 质谱(EI 70eV)…

📐 理化性质(数据库) 6 字段 MolGod评分:无来源
属性 值 单位 条件 来源
熔点 84.50 °C 1 atm
水溶性 soluble (≥999) g/L 25°C
密度 (ρ) 1.1300 g/cm³ 20°C
闪点 137.80 °C closed cup
自燃温度 240.00 °C in air
logP (辛醇/水) -0.700 — 25°C
📚 科学参考文献(芝加哥作者-日期格式) (12 来源)
  1. Haynes, William M., ed. 2024. CRC Handbook of Chemistry and Physics. 105th ed. Boca Raton: CRC Press/Taylor & Francis. ISBN 978-1-032-55554-4. ↗
  2. National Institute of Standards and Technology. 2024. "NIST Chemistry WebBook, SRD 69." Gaithersburg, MD: NIST. Accessed 2025-01-01. ↗
  3. Yaws, Carl L. 2014. The Yaws Handbook of Physical Properties for Hydrocarbons and Chemicals. 2nd ed. Oxford: Gulf Professional Publishing.
  4. PubChem. 2024. "PubChem Compound Database." National Library of Medicine, National Institutes of Health. Accessed 2025-01-01. ↗
  5. Marrero, J., and R. Gani. 2001. "Group-Contribution Based Estimation of Pure Component Properties." Fluid Phase Equilibria 183–184: 183–208. ↗
  6. Joback, K. G., and R. C. Reid. 1987. "Estimation of Pure-Component Properties from Group-Contributions." Chemical Engineering Communications 57 (1–6): 233–243. ↗
  7. Sangster, J. 1997. Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry. Chichester: Wiley. ISBN 978-0-471-97397-3.
  8. Mannhold, Raimund, and Han van de Waterbeemd. 2001. "Substructure and Whole Molecule Approaches for Calculating Log P." Journal of Computer-Aided Molecular Design 15 (4): 337–354. ↗
  9. Perrin, Ditlev D., Boyd Dempsey, and E. P. Serjeant. 1981. pKa Prediction for Organic Acids and Bases. London: Chapman and Hall. ISBN 0-412-21090-5.
  10. Constantinou, Leonidas, and Rafiqul Gani. 1994. "New Group Contribution Method for Estimating Properties of Pure Compounds." AIChE Journal 40 (10): 1697–1710. ↗
  11. Ertl, Peter, Bernhard Rohde, and Paul Selzer. 2000. "Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties." Journal of Medicinal Chemistry 43 (20): 3714–3717. ↗
🔄 浓度单位转换器 实时 MolGod_UNITCONV_1

输入Acrylamide浓度(任意单位),其余将自动计算。

分子量: 71.08 g/mol · IUPAC Gold Book ↗

⚗️ 转换公式及引用(每个公式)
转换分子式准确度来源
% (w/v) ↔ molarityc (mol/L) = (% × 10) / MW±0.5% rel. when density ≈ 1.0 g/mLIUPAC (2019)
millimolar ↔ molarc (mol/L) = mM × 10⁻³ExactCohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
molarity (mol/L)c = n/V = (m/MW)/V±0.1% (depends on MW precision)IUPAC (2019)
parts per million (mg/L) ↔ molarityc (mol/L) = ppm / (1000 × MW); equivalently ppm = mg/L for dilute aqueous±1% (density-independent for dilute solutions)IUPAC (2019)
mg/mL ↔ molarityc (mol/L) = (mg/mL × 1000) / MW / 1000 = mg/mL / MW × 1±0.2%Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
g/L ↔ molarityc (mol/L) = (g/L) / MW±0.1% (depends on MW precision)Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
mmol/L ↔ molarityc (mol/L) = mmol/L × 10⁻³ExactCohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
Celsius ↔ KelvinT(K) = t(°C) + 273.15±0.01 K (ITS-90 scale)BIPM (Bureau International des Poids et Mesures) (2019)
Celsius ↔ FahrenheitT(°F) = T(°C) × 9/5 + 32±0.1 °FThompson A, Taylor BN (2008)
density-corrected % ↔ molarityc (mol/L) = (%w/w × ρ × 10) / MW, ρ in g/mL±0.1% when ρ known to 3 decimalsCohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007)
📚 参考文献(8个权威来源)
  1. Thompson A, Taylor BN (2008). Guide for the Use of the International System of Units (SI). NIST Special Publication 811 · DOI: 10.6028/NIST.SP.811-2008
    → Primary SI standard for US scientific usage
  2. Cohen ER, Cvitaš T, Frey JG, Holmström B, Kuchitsu K, Marquardt R, Mills I, Pavese F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007). Quantities, Units and Symbols in Physical Chemistry — The IUPAC Green Book. RSC Publishing, 3rd ed. · DOI: 10.1039/9781847557889 · ISBN: 978-0-85404-433-7
    → Canonical IUPAC guide for chemistry quantities/units
  3. BIPM (Bureau International des Poids et Mesures) (2019). The International System of Units (SI), 9th edition. BIPM · ↗
    → International SI definitions (incl. redefined kilogram 2019)
  4. ISO/IEC (2022). Quantities and units — Part 1: General. International Organization for Standardization — ISO 80000-1:2022 · ↗
    → General rules for physical quantities and units
  5. ISO/IEC (2019). Quantities and units — Part 9: Physical chemistry and molecular physics. International Organization for Standardization — ISO 80000-9:2019 · ↗
    → Concentration / molality / amount-of-substance conventions
  6. Tiesinga E, Mohr PJ, Newell DB, Taylor BN (2021). CODATA recommended values of the fundamental physical constants: 2018. Rev. Mod. Phys. 93(2):025010 · DOI: 10.1103/RevModPhys.93.025010
    → Avogadro, gas constant, molar volume (2019 SI revision)
  7. IUPAC (2019). Compendium of Chemical Terminology — the IUPAC Gold Book (online). IUPAC · DOI: 10.1351/goldbook
    → Definitions of mass fraction, molality, normality, ppm, activity
  8. Mills IM, Cvitaš T, Homann K, Kallay N, Kuchitsu K (1988). Quantities, Units and Symbols in Physical Chemistry. Blackwell Scientific Publications, 1st ed. · ISBN: 0-632-01773-5
    → Historical predecessor of IUPAC Green Book
🧪 溶液制备向导 WIZARD MolGod_PREP_1
① 选择浓度
② 目标体积
③ 溶剂

计算依据: IUPAC Gold Book ↗, Merck ↗

溶剂兼容性MolGod_SOLV_1

基于水溶性和logP的估算。指示性数据——不能替代实验研究。

溶剂兼容性备注参考文献
Water+ 良好logP表明亲水性
EtOH+ 良好EtOH — 通用极性溶剂
Acetone~ 中等部分兼容
DCM- 差与极性溶剂兼容性差
DMSO+ 良好DMSO — 强非质子溶剂
THF~ 中等THF — 对强极性化合物有限
Hexane- 差在己烷中几乎不溶
CHCl3- 差与极性溶剂兼容性差

logP/溶解性的数据来源: logP: -0.70

📚 溶剂的科学参考文献(芝加哥作者-日期格式)——点击展开

每种溶剂均有5个独立的科学来源支持(NIST/CRC/IARC/Hansen/Reichardt/Smallwood/GESTIS)。完整引文如下。

Water · NIST CAS lookup ↗
  1. Rumble, John R., ed. 2023. CRC Handbook of Chemistry and Physics. 104th ed. Boca Raton, FL: CRC Press. [link ↗]
  2. International Association for the Properties of Water and Steam (IAPWS). 1997. "Release on the Static Dielectric Constant of Ordinary Water Substance." IAPWS R8-97. [link ↗]
  3. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Weinheim: Wiley-VCH. https://doi.org/10.1002/9783527632220. [link ↗]
  4. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. https://doi.org/10.1201/9781420006834. [link ↗]
  5. IFA. n.d. "Water." GESTIS Substance Database. Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung. Accessed April 25, 2026. [link ↗]
EtOH · NIST CAS lookup ↗
  1. Rumble, John R., ed. 2023. CRC Handbook of Chemistry and Physics. 104th ed. Boca Raton, FL: CRC Press. [link ↗]
  2. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Weinheim: Wiley-VCH. https://doi.org/10.1002/9783527632220. [link ↗]
  3. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. Hoboken, NJ: Wiley. https://doi.org/10.1002/9780470508183. [link ↗]
  4. Smallwood, Ian M. 1996. Handbook of Organic Solvent Properties. London: Arnold. https://doi.org/10.1016/B978-0-340-64578-9.X5000-9. [link ↗]
  5. IFA. n.d. "Ethanol." GESTIS Substance Database. Accessed April 25, 2026. [link ↗]
Acetone · NIST CAS lookup ↗
  1. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Weinheim: Wiley-VCH. https://doi.org/10.1002/9783527632220. [link ↗]
  2. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. [link ↗]
  3. Rumble, John R., ed. 2023. CRC Handbook of Chemistry and Physics. 104th ed. Boca Raton, FL: CRC Press. [link ↗]
  4. Smallwood, Ian M. 1996. Handbook of Organic Solvent Properties. London: Arnold. [link ↗]
  5. IFA. n.d. "Acetone." GESTIS Substance Database. Accessed April 25, 2026. [link ↗]
DCM · NIST CAS lookup ↗
  1. National Institute of Standards and Technology. n.d. "Methane, dichloro- (CAS 75-09-2)." NIST Chemistry WebBook, SRD 69. Accessed April 25, 2026. [link ↗]
  2. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. [link ↗]
  3. International Agency for Research on Cancer. 1999. "Dichloromethane." IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 71: 251–315. [link ↗]
  4. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Weinheim: Wiley-VCH. [link ↗]
  5. IFA. n.d. "Dichloromethane." GESTIS Substance Database. Accessed April 25, 2026. [link ↗]
DMSO · NIST CAS lookup ↗
  1. Wypych, George. 2019. Handbook of Solvents. Volume 1: Properties. 3rd ed. Toronto: ChemTec Publishing. https://doi.org/10.1016/C2018-0-02235-3. [link ↗]
  2. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Weinheim: Wiley-VCH. [link ↗]
  3. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. [link ↗]
  4. National Institute of Standards and Technology. n.d. "Methane, sulfinylbis- (CAS 67-68-5)." NIST Chemistry WebBook. Accessed April 25, 2026. [link ↗]
  5. IFA. n.d. "Dimethyl sulfoxide." GESTIS Substance Database. Accessed April 25, 2026. [link ↗]
THF · NIST CAS lookup ↗
  1. Armarego, Wilfred L. F., and Christina Li Lin Chai. 2009. Purification of Laboratory Chemicals. 6th ed. Oxford: Butterworth-Heinemann. https://doi.org/10.1016/B978-1-85617-567-8.50003-3. [link ↗]
  2. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. [link ↗]
  3. National Institute of Standards and Technology. n.d. "Furan, tetrahydro- (CAS 109-99-9)." NIST Chemistry WebBook. Accessed April 25, 2026. [link ↗]
  4. Smallwood, Ian M. 1996. Handbook of Organic Solvent Properties. London: Arnold. [link ↗]
  5. IFA. n.d. "Tetrahydrofuran." GESTIS Substance Database. Accessed April 25, 2026. [link ↗]
Hexane · NIST CAS lookup ↗
  1. National Institute of Standards and Technology. n.d. "Hexane (CAS 110-54-3)." NIST Chemistry WebBook. Accessed April 25, 2026. [link ↗]
  2. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. [link ↗]
  3. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. Hoboken, NJ: Wiley. [link ↗]
  4. Agency for Toxic Substances and Disease Registry. 1999. Toxicological Profile for n-Hexane. Atlanta, GA: U.S. Department of Health and Human Services. [link ↗]
  5. IFA. n.d. "n-Hexane." GESTIS Substance Database. Accessed April 25, 2026. [link ↗]
CHCl3 · NIST CAS lookup ↗
  1. International Agency for Research on Cancer. 1999. "Chloroform." IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 73: 131–182. [link ↗]
  2. National Institute of Standards and Technology. n.d. "Methane, trichloro- (CAS 67-66-3)." NIST Chemistry WebBook. Accessed April 25, 2026. [link ↗]
  3. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. [link ↗]
  4. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Weinheim: Wiley-VCH. [link ↗]
  5. IFA. n.d. "Chloroform." GESTIS Substance Database. Accessed April 25, 2026. [link ↗]
溶解性理论(应用于相容性预测):
  1. Yalkowsky, Samuel H., and Shri C. Valvani. 1980. "Solubility and Partitioning I: Solubility of Nonelectrolytes in Water." Journal of Pharmaceutical Sciences 69 (8): 912–922. https://doi.org/10.1002/jps.2600690814 — General Solubility Equation (GSE): logS = 0.5 − logP − 0.01(MP−25).
  2. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. Boca Raton, FL: CRC Press. https://doi.org/10.1201/9781420006834 — HSP三元组(dD, dP, dH)+ Ra公式。
  3. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Weinheim: Wiley-VCH. https://doi.org/10.1002/9783527632220 — E_T(30) polarity scale, solwatochromia.
  4. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. Hoboken, NJ: Wiley. https://doi.org/10.1002/9780470508183 — Eluotropic series, polarity index.
  5. PubChem Compound Database — CAS 79-06-1 lookup ↗ — logP (XLogP3), water solubility experimental + predicted.

完整参考文献位于页面底部的参考文献折叠面板——芝加哥格式手册第17版作者-日期格式。

🛡️ 安全 — CAS 79-06-1MolGod_SAFEHUB_MAIN
数据限制说明。 本页安全信息仅供参考,不能替代完整的安全数据表(SDS)。使用产品前,请查阅制造商当前的安全数据表以及GHS/CLP指南。CLP分类适用于纯散装物质,不适用于商业制剂。

GHS/CLP分类——(EC) No 1272/2008法规 + UN GHS Rev. 9 (2021)。

⚠️ 危险 (Danger)
GHS06 — 毒性
GHS06 毒性
GHS07 — 刺激性/有害
GHS07 刺激性/有害
GHS08 — 健康危害
GHS08 健康危害

🚨 危险说明(H)

  • H350 — 可能致癌(说明接触途径――如已确证无其他接触途径造成这一危害)
  • H340 — 可能导致遗传性缺陷(说明接触途径――如已确证无其他接触途径造成这一危害)
  • H361f — 怀疑对生育能力造成伤害
  • H332 — 吸入有害
  • H312 — 皮肤接触有害
  • H301 — 吞咽可中毒
  • H372 — 长期或反复接触会对器官造成伤害(说明已知的所有受影响器官)( 说明接触途径――如已确证无其他接触途径造成这一危害)
  • H315 — 造成皮肤刺激
  • H319 — 造成严重眼刺激
  • H317 — 可能导致皮肤过敏反应

🛡 防范说明(P)

  • P203 — 使用前取得、阅读并遵循所有安全说明书。

✓ 根据CLP法规(EC) 1272/2008附件VI的统一分类(官方、具有约束力的分类)。 索引号:616-003-00-0。

参考文献(芝加哥格式): European Chemicals Agency. "acrylamide; prop-2-enamide, Index No. 616-003-00-0." In Table 3 of Annex VI to Regulation (EC) No 1272/2008 (CLP Regulation), 23rd Adaptation to Technical Progress. Helsinki: European Chemicals Agency, 2026. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp.

⚠ IARC — 组 2A: 可能对人类致癌. (IARC/WHO对致癌性证据的独立评估 — 补充上述CLP分类。)
参考文献(芝加哥格式): IARC. 2026. IARC Monographs on the Identification of Carcinogenic Hazards to Humans: CAS 79-06-1. Lyon, France: International Agency for Research on Cancer, World Health Organization. https://monographs.iarc.who.int/list-of-classifications/. (Accessed 2026-11-12.)
来自本地MOL-GOD列表(快照)的分类 — 未与当前IARC列表核实。 验证

翻译:CLP 法规 (EC) 1272/2008,附件 III 和 IV。数据:PubChem/NLM。

📚 综合科学参考文献 — Chicago Author-Date 10 来源

从所有Safety Hub选项卡收集的参考文献。CAS号: 79-06-1 · PubChem ↗

  1. Parlament Europejski i Rada UE. 2008. "Rozporządzenie (WE) nr 1272/2008 w sprawie klasyfikacji, oznakowania i pakowania substancji (CLP)." Dz.Urz. UE L 353. [↗] GHS,法规
  2. United Nations Economic Commission for Europe (UNECE). 2021. "Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Ninth Revised Edition." United Nations, Geneva. [↗] GHS
  3. Goldfrank, Lewis R., Robert S. Hoffman, Mary Ann Howland, et al.. 2019. "Goldfrank's Toxicologic Emergencies, 11th ed.." McGraw-Hill Education, New York. ISBN 978-1-25-985961-8. Pierwsza pomoc, Toksykologia
  4. National Institute for Occupational Safety and Health (NIOSH). 2023. "NIOSH Pocket Guide to Chemical Hazards (DHHS Publ. 2005-149)." U.S. Department of Health and Human Services / CDC, Cincinnati, OH. [↗] Pierwsza pomoc, PPE, Toksykologia
  5. European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms." CEN, Brussels. [↗] PPE
  6. UNECE. 2023. "European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." United Nations, Geneva. [↗] Utylizacja, Regulacje
  7. National Fire Protection Association (NFPA). 2022. "NFPA 400 — Hazardous Materials Code." NFPA, Quincy, MA. [↗] Magazynowanie
  8. Urben, P.G. (ed.). 2017. "Bretherick's Handbook of Reactive Chemical Hazards, 8th ed.." Butterworth-Heinemann / Elsevier, Oxford. [↗] Magazynowanie
  9. Ministerstwo Klimatu i Środowiska RP. 2023. "Baza danych o produktach i opakowaniach oraz o gospodarce odpadami (BDO)." Ministerstwo Klimatu i Środowiska, Warszawa. [↗] Utylizacja
  10. International Agency for Research on Cancer (IARC / WHO). 2024. "IARC Monographs on the Identification of Carcinogenic Hazards to Humans — List of Classifications." WHO, Lyon. [↗] Toksykologia

具有自身参考文献的选项卡(紧急情况、个人防护装备、储存、废物)在其各自章节中包含额外的书目条目。

📈 分析统计(t检验·RSD·Grubbs·Q-Dixon) ICH Q2

粘贴一系列重复测量结果(CSV或每行一个数字)。计算器将计算平均值、标准差和95%置信区间,并检测异常值(Grubbs + Dixon Q)。

分隔符:逗号、空格、制表符、换行。至少3个测量值。
📐 统计公式
  • x̄ = Σxᵢ / n — 算术平均值
  • s² = Σ(xᵢ - x̄)² / (n-1) — 样本方差
  • s = √s² — 标准差
  • RSD% = (s / x̄) × 100% — 相对标准差
  • CI₉₅ = x̄ ± t(0.05, n-1) × s / √n — Student's t
  • G = |xᵢ - x̄| / s — Grubbs检验
  • Q = |xsuspect - xnearest| / |xmax - xmin| — Dixon Q-test

来源:ICH Q2(R2) 分析方法验证 · ICH PDF ↗

🧪 缓冲液配方计算器 唯一

从 20 种常用缓冲体系列表中选择 → 输入目标 pH → 获得精确配方,包括称量质量。

步骤 1:选择缓冲体系

📜 配方历史记录(最近 10 条)
🔬 HPLC/GC方法 (3 方法)
📄
Biochemical Characterization of Thermostable Acrylamide Amidohydrolase from Aspergillus fumigatus with Potential Activity for Acrylamide Degradation in Various Food Products
HPLCCurrent Microbiology202388% ✓CC-BYResearch method (specificity, robustness)
色谱柱: C18, 1 μm
相: mobile phase was methanol/acetonitrile/water (90:5:5, v/v/v) at a flow rate 1 ml/min for…
检测: UV 425 nm
流速: 1.00 mL/min
温度: 30.0 °C
Gradient: s: at the beginning (10% A and 90% B); up…
El-Sayed A, Elghamry H, Yassin M. Biochemical Characterization of Thermostable Acrylamide Amidohydrolase from Aspergillus fumigatus with Potential Activity for Acrylamide Degradation in Various Food Products. Current Microbiology. 2023;81:30. doi:10.1007/s00284-023-03544-1
Acrylamide is the major by-product of the Maillard reactions in foods with the overheating processes of L-asparagine-rich foods with reducing sugars that usually allied with neurotoxicity and carcinogenicity. Several approaches have been used to prevent the formation of acrylamide, however, degrading the already formed acrylamide in foods remains unequivocal. Acrylamide hydrolyzing enzyme “amidohydrolase” is one of the most promising enzymes for acrylamide degradation in foods. So, amidohydrolase “amidase” from thermotolerant Aspergillus fumigatus EFBL was purified to their electrophoretic homogeneity by gel-filtration and ion-exchange chromatography, with overall purification folds 2.8 and yield 9.43%. The apparent molecular subunit structure of the purified A. fumigatus amidase was 50 kDa, with highest activity at reaction temperature of 40 °C and pH of 7.5 The enzyme displayed a significant thermal stability as revealed from the value of T1/2 (13.37 h), and thermal denaturation rate (Kr 0.832 × 10–3 min) at 50 °C, with metalloproteinic identity. The purified enzyme had a significant activity for acrylamide degradation in various food products such as meat, cookies, potato chips, and bread as revealed from the HPLC analysis and LC–MS analysis. So, with the purified amidase, the acrylamide in the food products was degraded by about 95% to acrylic acid, ensuring the possibility of using this enzyme in abolishing the toxic acrylamide in the foods products. This is the first report exploring the potency of A. fumigatus amidase for an actual degradation of acrylamide in foods efficiently. Further biochemical analyses are ongoing to assess the affinity of this enzyme for selective hydrolyses of acrylamide in foods, without affecting the beneficial stereochemical related compounds.Supplementary InformationThe online version contains supplementary material available at 10.1007/s00284-023-03544-1.
📄
Effect of Brewing Methods on Acrylamide Content and Antioxidant Activity: Studying Eight Different Filter Coffee Preparations
HPLC-MSAntioxidants202395% ✓CC-BYResearch method (specificity, robustness)
色谱柱: C18, 0.2 μm
相: mobile phase consisted of water (A) and acetonitrile (B), both containing 0
检测: UV 325 nm
流速: 0.80 mL/min
温度: 18.0 °C
Inj.: 2 μL
Gradient: elution mode
Santanatoglia A, Angeloni S, Bartolucci D, Fioretti L, Sagratini G, Vittori S, et al. Effect of Brewing Methods on Acrylamide Content and Antioxidant Activity: Studying Eight Different Filter Coffee Preparations. Antioxidants. 2023;12:1888. doi:10.3390/antiox12101888
The aim of this study was to investigate the parameters affecting the extraction of positive molecules such as chlorogenic acids and antioxidants, as well as potentially carcinogenic substances such as acrylamide, in different coffee brewing methods. Three coffee varieties, each assigned a different roasting degree, were used to prepare coffee brews following eight different preparation methods. Acrylamide was quantified using the HPLC-MS/MS instrument, while chlorogenic acids and caffeine were quantified using the HPLC-DAD system. Three spectrophotometric analyses were also performed (DPPH, TFC and TPC) to evaluate antioxidant activity. The results showed that the main brewing parameters, which have the greatest influence on the final content of these compounds, were the volume of water used, more specifically the brewing ratio (coffee to water ratio), the extraction time and the particle size of the coffee powder. In addition, the variables that have the greatest impact on the discrimination of the preparation methods studied are total chlorogenic acid content, TFC, TPC, caffeine and the DPPH assay. For this reason, the recipe and infusion parameters used for each of the extraction systems are the key factors that determine the extraction of coffee components and, consequently, the quality of the cup.
acrylamideantioxidant activitybrewing methodschlorogenic acidscoffeeHPLC-MS/MSHPLC-DAD
📄
Simultaneous Determination of Furanic Compounds and Acrylamide in Insect-Based Foods by HPLC-QqQ-MS/MS Employing a Functionalized Mesostructured Silica as Sorbent in Solid-Phase Extraction
LC-MS/MSFoods202190% ✓CC-BYResearch method (specificity, robustness)
色谱柱: NH2, 0.45 μm
相: mobile phases: solvent A (ACN) and solvent B (Milli-Q Water), both phases…
检测: MS
流速: 0.30 mL/min
温度: 20.0 °C
Inj.: 100 μL
Gradient: elution mode
González-Gómez L, Morante-Zarcero S, Pérez-Quintanilla D, Sierra I. Simultaneous Determination of Furanic Compounds and Acrylamide in Insect-Based Foods by HPLC-QqQ-MS/MS Employing a Functionalized Mesostructured Silica as Sorbent in Solid-Phase Extraction. Foods. 2021;10:1557. doi:10.3390/foods10071557
Insect-based products are novel foods (NF) that merit careful study. For this reason, in this work a method has been developed for the simultaneous analysis of four food processing contaminants (FPC), acrylamide (AA), 5-hydroxymethylfurfural, (HMF), 5-methylfurfural (MF) and furfural (F), in insect-based products (bars, crackers and flours) by high-performance liquid chromatography coupled to triple quadrupole mass spectrometry (HPLC-QqQ-MS/MS). The method consisted of a solid-liquid extraction (SLE) with acidified water, followed by solid-phase extraction (SPE), using 100 mg of a sorbent based on mesostructured silica with a large pore functionalized with amino groups (SBA-15-LP-NH2). The analytical method was properly optimized and validated in a representative bar sample of pineapple & coconut with cricket flour (Ins-B-Pine-Coco) showing good accuracy, with recoveries ranging from 70–101% for the four analytes and adequate precision (RSD < 9%). Good linearity (R2 ≥ 0.995) and low method quantification limits for AA (between 1.3–1.4 µg/g), F (between 7.9–8.8 µg/g), MF (between 3.1–6.5 µg/g) and HMF (between 1.5–3.3 µg/g) were also obtained in all samples studied. The proposed method was successfully applied in eleven insect-based foods. Results revealed that insect-based bars can be a good alternative to traditional cereal bars to reduce dietary exposure to HMF; but, in order to reduce the exposure to AA, alternative formulations must be evaluated in the design of innovative insect-based crackers.
acrylamide5-hydroxymethylfurfuralfurfural5-methylfurfuralinsect-based foods
📈 方法验证(ICH Q2)

无验证数据。请联系方法作者。

参数依据: ICH Q2(R2) ↗

📋 方法比较
技术 色谱柱 分析时间 检测 流动相 来源
HPLC C18 — UV 425 nm mobile phase was methanol/acetonitrile/water (90:5:5, v/v/v) at a… DOI ↗
HPLC-MS C18 — UV 325 nm mobile phase consisted of water (A) and acetonitrile… DOI ↗
LC-MS/MS NH2 — MS mobile phases: solvent A (ACN) and solvent B… DOI ↗
🔧 HPLC/GC故障排除
宽峰 / 拖尾
原因: 色谱柱磨损、流动相pH值不当、色谱柱过载、死体积
解决方案: 更换色谱柱,检查缓冲液pH值(±0.2),减少进样体积,检查接头
基线漂移
原因: 流动相污染、梯度问题、温度不稳定
解决方案: 对流动相脱气,0.22 µm过滤,稳定色谱柱温度,冲洗系统
无峰
原因: 波长错误,分析物未洗脱,热分解,相错误
解决方案: 检查λmax,延长梯度,降低温度,更换流动相
鬼峰
原因: 系统污染、残留、样品瓶污染
解决方案: 清洗系统(甲醇/水),使用新小瓶,进样空白
回收率低
原因: 吸附到壁上、提取不足、分解
解决方案: 添加内标,硅烷化玻璃器皿,优化萃取,检查稳定性

来源: Snyder, Kirkland & Dolan ↗, Waters ↗

📊 HPLC方法验证(ICH Q2(R1)) PARTIAL

3 metrics need experimental data

参数 值 单位 ICH Q2标准 Status
线性(R²) 无数据 unitless R² ≥ 0.999(生物分析中≥0.99) —
LOD (S/N = 3:1) 无数据 ng/mL 信噪比≥3:1(最低可检测浓度) —
LOQ (S/N = 10:1) 无数据 ng/mL 信噪比≥10:1(定量限通常≥3倍检出限) —
精密度(日内RSD,n=6) 无数据 % RSD 原料药RSD ≤ 2%(日内)/ ≤ 3%(日间) —
准确度(回收率,3个水平) 无数据 % (target 100±2%) Recovery 98-102% (target 100%) —
线性范围 无数据 例如0.1-100 ng/mL 至少为标称浓度的80-120% —
选择性/专属性 无数据 qualitative 无干扰——分析物峰完全分离(Rs ≥ 2.0) —
耐用性 无数据 ±5%变化时RSD < 2% 参数微小变化时 RSD < 2% —
图例: ✓ PASS ⚠ CAUTION ✗ FAIL — NO_DATA
📚 科学参考文献(芝加哥作者-日期格式)——点击展开

分析方法验证标准——4个独立来源(ICH + USP + AOAC + Snyder)。

  1. International Conference on Harmonisation (ICH). 2005. Validation of Analytical Procedures: Text and Methodology Q2(R1). ICH Expert Working Group. [link ↗] — Gold-standard ICH guideline — accepted by EMA, FDA, MHLW, NMPA
  2. United States Pharmacopeia (USP) Convention. 2024. USP General Chapter <621> Chromatography. USP-NF 2024 ed. USP. [link ↗]
  3. AOAC International. 2016. Appendix F: Guidelines for Standard Method Performance Requirements. AOAC INTERNATIONAL. [link ↗] — AOAC SMPR — alternative to ICH Q2 for food/dietary supplements
  4. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. John Wiley & Sons. ISBN 978-0-470-16754-0. https://doi.org/10.1002/9780470508183 [link ↗] — Industry standard textbook — Chapter 11 covers method validation
  5. Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. Practical HPLC Method Development. 2nd ed. Wiley. ISBN 978-0-471-00703-6. — Classic method-development reference (DryLab heritage).
  6. Rozet, Eric, et al.. 2013. Analysis of recent pharmaceutical regulatory documents on analytical method validation. https://doi.org/10.1016/j.chroma.2007.03.111 [link ↗] — Comparison of FDA / EMA / ICH validation expectations — used for ICH Q2(R1) interpretation.
  7. Heyden, Yvan Vander, et al.. 2009. Robustness of pharmaceutical liquid chromatographic methods. https://doi.org/10.1016/j.jchromb.2008.10.052 [link ↗] — Plackett-Burman design for robustness — basis of ICH Q2 §3.7.
  8. Dong, Michael W.. 2019. HPLC and UHPLC for Practicing Scientists. 2nd ed. Wiley. ISBN 978-1-119-31378-3. https://doi.org/10.1002/9781119313793 [link ↗] — Modern (UHPLC) update of validation chapter — practical RSD/LOD examples.
  9. Meyer, Veronika R.. 2010. Practical High-Performance Liquid Chromatography. 5th ed. Wiley. ISBN 978-0-470-68218-0. — European pharmacopeial perspective — complements USP/AOAC.
  10. Kazakevich, Yuri V., and Rosario LoBrutto, eds.. 2007. HPLC for Pharmaceutical Scientists. Wiley-Interscience. ISBN 978-0-471-68162-4. https://doi.org/10.1002/9780470087954 [link ↗] — Pharma-focused validation case studies (specificity, robustness).
  11. European Medicines Agency (EMA). 2011. Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009. EMA Committee for Medicinal Products for Human Use. [link ↗] — EMA bioanalytical companion to ICH Q2(R1) for clinical samples.

· ⚠ SVHC/REACH法规警告 ↑

🔧 HPLC故障排除——决策树 6 常见问题

12种最常见HPLC问题的诊断及决策树(每个问题5个步骤)。 来源: Snyder/Kirkland/Dolan 3rd ed. Chapter 17 + LCGC LC Troubleshooting columns 1989-2024.

宽峰 medium

症状: 色谱图上所有峰都比预期宽(半峰宽 > 2倍正常值)

🔍 诊断树:
  1. 1. 检查是所有峰变宽还是只有部分峰
    → 是: 所有峰→仪器问题(色谱柱或系统)
    → 否: 仅部分峰→化学问题(特定分析物与色谱柱的相互作用)
  2. 2. 更换测试柱——问题是否消失?
    → 是: 色谱柱已耗尽——填料损坏,前几毫米有空隙。更换。
    → 否: 液相色谱系统问题
  3. 3. 检查死体积——进样环、连接件、检测器
    → 是: 对于4.6 mm色谱柱,进样环 > 100 µL或连接松动→更换卡套,缩短管路
    → 否: 继续诊断
  4. 4. 温度测试:将色谱柱从25°C升至40°C
    → 是: 峰变窄→传质动力学过慢(升高温度)
    → 否: Continue
  5. 5. 检查流速与该色谱柱的最佳范德姆特值
    → 是: 4.6mm/5µm的最佳流速为1.0 mL/min,2.1mm/3µm的最佳流速为0.4 mL/min
    → 否: Continue
⚠️ 常见原因:
  • 色谱柱已耗尽(无保护柱时超过2000次进样)
  • 系统死体积 > 100 µL(错误的进样环、长管路、卡套松动)
  • 温度过低(传质动力学)
  • 流速超出范德姆特最佳值
  • 样品溶剂比流动相A更强
✓ 修复方法:
  • ✓ 更换色谱柱(当>2000次进样时)
  • ✓ 检查所有连接——管路尽可能短
  • ✓ 将色谱柱温度升至40°C(如果物质稳定)
  • ✓ 将流速降至van Deemter最佳值
  • ✓ 将样品溶解在流动相A中(而非纯有机相)
峰拖尾(拖尾因子T > 1.5) high

症状: 峰在晚洗脱侧有延伸的“拖尾”(根据USP,不对称度T = b/a > 1.5)

🔍 诊断树:
  1. 1. 物质是否含有碱性基团(氨基、吡啶)?
    → 是: 是 → 硅醇相互作用!向流动相A中添加0.1% TFA或5-10 mM TEA。
    → 否: Continue
  2. 2. 检查流动相pH与物质pKa的关系
    → 是: pH = pKa ± 1 → 部分电离,峰分裂。使pH远离pKa ≥ 2个单位。
    → 否: Continue
  3. 3. 检查色谱柱使用时间(>1500次进样?)
    → 是: 是 → 硅醇暴露(柱流失)。更换为具有更高封端度的色谱柱(XTerra、Symmetry)。
    → 否: Continue
  4. 4. 样品是否含有金属(来自玻璃小瓶的Fe、Cu)?
    → 是: 是 → 使用II型无色小瓶或PFA小瓶。向样品中添加0.1mM EDTA。
    → 否: Continue
⚠️ 常见原因:
  • 硅醇相互作用(碱性分析物 + 硅胶游离硅醇)
  • pH处于分析物pKa边界(峰分裂)
  • 旧色谱柱(柱流失,高硅醇活性)
  • 样品中的金属(螯合 → 拖尾)
  • 色谱柱过载(4.6mm色谱柱上>50 µg)
✓ 修复方法:
  • ✓ 向流动相A中加入0.1% TFA(UV)或0.1%甲酸(LC-MS)
  • ✓ 选择高纯度封端的色谱柱:Waters XBridge BEH、Phenomenex Kinetex
  • ✓ 在pH值距离pKa ≥ 2个单位的条件下操作
  • ✓ 向样品中加入0.1mM EDTA(螯合Fe/Cu)
  • ✓ 对于4.6 mm色谱柱,将进样体积减少至≤ 20 µL
基线漂移 medium

症状: 基线在>5分钟内系统性上升或下降

🔍 诊断树:
  1. 1. 是否使用梯度(B%增加)?
    → 是: 是 → 流动相A与B在检测波长下吸收不同。溶剂更换导致UV截止波长变化。检查有机相UV吸光度百分比。
    → 否: 继续(等度)
  2. 2. 检查色谱柱温度——是否稳定在±0.5°C?
    → 是: 是(稳定)→ 继续
    → 否: 不稳定 → 开启柱温箱(>25°C受控)
  3. 3. 测试:关闭自动进样器,仅运行泵+色谱柱+检测器
    → 是: 漂移消失 → 自动进样器污染(清洁针头、隔垫)
    → 否: Continue
  4. 4. 检查灯的使用时间(UV用D2灯)
    → 是: 是(>1500小时)→ 更换灯
    → 否: Continue
⚠️ 常见原因:
  • 梯度洗脱,流动相UV截止值不同
  • 色谱柱温度不稳定
  • 自动进样器针头/隔垫污染
  • UV灯老化(>1500h)
  • 检测器流通池污染
  • 色谱柱未平衡(<10个柱体积)
✓ 修复方法:
  • ✓ 用100% A预平衡色谱柱10-15个柱体积
  • ✓ 开启色谱柱恒温箱,温度30-40°C稳定
  • ✓ 用50:50乙腈-水溶液清洗检测器流通池
  • ✓ 如果D2灯使用时间>1500小时,请更换
  • ✓ 使用基线扣除(Chromeleon、Empower原生功能)
无峰/丢失峰 critical

症状: 预期分析物峰未出现在色谱图上

🔍 诊断树:
  1. 1. 进样是否实际发生?
    → 是: 检查自动进样器日志、泵压力(进样时应下降)
    → 否: 自动进样器问题→检查定量环、进样针、样品瓶中的样品
  2. 2. 样品是否在样品瓶中(体积正确,未蒸发)?
    → 是: Continue
    → 否: 无样品——重新移液
  3. 3. 样品稳定性——制备时间是否超过24小时?
    → 是: 是→降解。重新制备新鲜样品。
    → 否: Continue
  4. 4. 检查检测波长与物质的λmax是否匹配
    → 是: 检测波长与λmax不匹配→无信号。扫描DAD 200-400nm。
    → 否: Continue
  5. 5. 测试:进样纯标准品(已知浓度,新鲜)
    → 是: 标准品出峰→样品问题(基质、衍生化)
    → 否: 标准品也无峰→系统问题(色谱柱、流动相、梯度)
⚠️ 常见原因:
  • 样品未从样品瓶中抽取(自动进样器故障)
  • 样品降解(超过24小时,pH/温度/光照)
  • 检测波长错误
  • 流动相错误(例如忘记加TFA)
  • 色谱柱接反/固定相错误
  • 物质在死时间(V0)洗脱→无保留,不可见
✓ 修复方法:
  • ✓ 严格按照协议重新制备新鲜样品
  • ✓ 紫外-可见DAD扫描200-400nm并搜索λmax
  • ✓ 检查流动相组成——是否添加了TFA?
  • ✓ 测试色谱柱反向(小心!)
  • ✓ 对于保留时间<1分钟——降低B比例,用甲醇代替乙腈
  • ✓ 检查wp_molgod_hplc_methods中的“expected_rt”表
压力过高 critical

症状: 泵压力>色谱柱最大压力的80%或系统因高压错误停机

🔍 诊断树:
  1. 1. 检查色谱柱是否连接正确(箭头方向)
    → 是: OK
    → 否: 色谱柱接反→将其翻转(切勿反向安装运行)
  2. 2. 测试:从系统中移除色谱柱,仅运行泵+检测器
    → 是: 压力降至 <50 bar → 色谱柱问题(堵塞)
    → 否: 压力保持高位 → 在线过滤器堵塞,烧结滤片污染
  3. 3. 检查预柱过滤器(在线烧结滤片)
    → 是: 污染且变棕色 → 更换
    → 否: Continue
  4. 4. 用 50:50 ACN:H2O 反向冲洗(不带色谱柱)——问题消失?
    → 是: 颗粒卡在第一毫米处——冲洗 30 分钟可能恢复
    → 否: 更换色谱柱
⚠️ 常见原因:
  • 在线过滤器(烧结滤片)被颗粒堵塞
  • 缓冲盐析(高 %B 时沉淀)
  • 样品含有悬浮物(进样前用 0.22 µm 过滤)
  • 色谱柱堵塞(柱床压实)
  • 梯度含缓冲液相 + 高有机相 → 盐沉淀
✓ 修复方法:
  • ✓ 进样前务必用0.22 µm PVDF过滤样品
  • ✓ 每100次进样(或压力升高>20%时)更换在线过滤器
  • ✓ 不要使用>20mM磷酸盐缓冲液+>70%乙腈(盐会析出)
  • ✓ 用50:50乙腈:水反向冲洗色谱柱30分钟(如果制造商允许)
  • ✓ 使用4×3mm预柱保护主色谱柱
鬼峰 high

症状: 色谱图上校准中不存在的无法解释的峰

🔍 诊断树:
  1. 1. 测试:空白进样(纯样品溶剂)
    → 是: 出现鬼峰 → 系统或洗脱液污染
    → 否: 仅与样品一起出现 → 基质
  2. 2. 鬼峰是否随梯度增大(在高 %B 下洗脱)?
    → 是: 是 → 色谱柱过载或前一次运行中的强保留物质
    → 否: 与梯度无关 → 自动进样器残留
  3. 3. Increase carryover wash (between injections)
    → 是: 有帮助 → 残留是原因。使用更强的清洗程序。
    → 否: Continue
  4. 4. 纯水进样——是否有峰?
    → 是: 是 → 水源污染(来自 DI 系统的有机物)
    → 否: Continue
⚠️ 常见原因:
  • 自动进样器针/定量环中的残留
  • 洗脱液污染(即使是 HPLC 级)
  • 前一次运行中的强保留组分
  • 样品瓶中的塑料(邻苯二甲酸酯、来自瓶盖的 PEG)
  • 纯化不充分的去离子水
✓ 修复方法:
  • ✓ 加强清洗程序:100% B → 100% A → 50:50(3个循环)
  • ✓ 校准前进行强清洗:100% DMSO或100%甲醇
  • ✓ 如有疑问,用0.22 µm PTFE过滤洗脱液
  • ✓ 使用琥珀色玻璃瓶和聚四氟乙烯内衬盖盛装样品
  • ✓ 定期进行梯度升至100% B并持续10分钟(清洗)
📚 科学参考文献(芝加哥作者-日期格式)——点击展开
  1. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. John Wiley & Sons. Chapter 17 (Troubleshooting) pp. 559-616. ISBN 978-0-470-16754-0. https://doi.org/10.1002/9780470508183 [link ↗]
  2. Dolan, John W.. 2014. LC Troubleshooting (monthly column 1989-2024). LCGC North America. [link ↗] — John Dolan 35-letnia seria miesięcznych artykułów problemowych
  3. Kromidas, Stavros. 2017. HPLC Made to Measure: A Practical Handbook for Optimization. 2nd ed. Wiley-VCH. ISBN 978-3-527-31377-1. — Praktyczny przewodnik problem-solving dla labs analitycznych
  4. Dolan, John W.. 2013. When to Modify Method Conditions. 192-199. [link ↗] — Decision flow for changing flow rate / temperature / %B vs swapping columns.
  5. Dong, Michael W.. 2019. HPLC and UHPLC for Practicing Scientists. 2nd ed. Wiley. ISBN 978-1-119-31378-3. https://doi.org/10.1002/9781119313793 [link ↗] — Chapter 9 covers troubleshooting modern UHPLC systems (sub-2 µm particles).
  6. Meyer, Veronika R.. 2010. Practical High-Performance Liquid Chromatography. 5th ed. Wiley. ISBN 978-0-470-68218-0. — Solid step-by-step problem isolation chapter (eluents, columns, instruments).
  7. Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. Practical HPLC Method Development. 2nd ed. Wiley. ISBN 978-0-471-00703-6. — Method-development companion volume with troubleshooting cross-refs.
  8. Carr, Peter W.. 2009. The new physical chemistry of HPLC. 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗] — Theoretical basis for diagnosing efficiency losses (mass-transfer, eddy diffusion).
  9. Heyden, Yvan Vander, et al.. 2009. Robustness of pharmaceutical liquid chromatographic methods. 2120-2129. https://doi.org/10.1016/j.jchromb.2008.10.052 [link ↗] — How to diagnose method failures vs. system failures (Plackett-Burman).
  10. Engelhardt, Heinz. 2014. 100 Years of Chromatography. 2nd ed. Wiley-VCH. ISBN 978-3-527-33473-5. — Historical context for ghost-peak phenomenology (silica chemistry).
  11. Stoll, Dwight R., and Peter W. Carr. 2017. Two-Dimensional Liquid Chromatography: A State of the Art Tutorial. 519-531. https://doi.org/10.1021/acs.analchem.6b03506 [link ↗]
  12. Carr, Peter W.. 2009. The new physical chemistry of HPLC. 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗]
  13. Wu, Naijun, and Anton M. Clausen. 2007. Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations. 1167-1182. https://doi.org/10.1002/jssc.200700026 [link ↗]
  14. Engelhardt, Heinz. 2014. 100 Years of Chromatography. 2nd ed. Wiley-VCH. ISBN 978-3-527-33473-5.
  15. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. Probabilistic approach to peak deconvolution in chromatography. 8525-8531. https://doi.org/10.1021/ac101742z [link ↗]
🧪 溶解性和溶剂兼容性 MolGod_SOLUB_1
分子
Acrylamide
分子式
C3H5NO
logP
-0.70
摩尔质量(g/mol)
71.08
极性
亲水性(极性)

⚠️ HSP估算(文献/基团贡献法)。指示性数据——不能替代实验研究。

溶剂 兼容性 Ra 可视化 GC-MS HPLC 应用 参考文献
Water (H₂O)− 差25.7
✗ NieA (aqueous) (RP)
缓冲液细胞培养分析级亲水萃取
Ethanol (EtOH)+ 良好7.0
✗ NieA/B modifier (RP/NP)
萃取光谱学(UV-Vis)合成HPLC改性剂
Methanol (MeOH)+ 良好9.0
✗ NieA/B (RP) (RP)
HPLC (eluent)LC-MSKarl FischerUV-transparent do 205 nm
Acetone~ 平均13.1
✗ NieB modifier (NP)
GC headspace结晶脱脂合成
Acetonitrile (ACN)− 差15.6
✗ NieB (RP) (RP)
HPLC洗脱液(黄金标准)LC-MS (wolny cut-off UV 190 nm)肽分析
DMSO~ 平均9.5
✗ NieN/A (N/A)
NMR (d6-DMSO)细胞生物学(低温保存)药物递送合成
THF~ 平均12.2
✗ NieB (NP) (NP)
GPC/SEC(聚合物分析)格氏合成有机金属
DCM (CH₂Cl₂)~ 平均13.0
✓ TakB (NP) (NP)
萃取NP-HPLCGC-MS结晶(反溶剂法)
Chloroform (CHCl₃)− 差14.9
✓ TakN/A (toxic) (N/A)
NMR (CDCl3)脂质提取(Folch法)NP-TLC
Hexane− 差22.7
✓ TakA (NP) (NP)
NP-HPLC油脂提取(脂质)GC-MSTLC (NP)
Toluene− 差18.9
✓ TakB (NP) (NP)
NMR (d8-toluene)合成Dean-Stark共沸干燥
📚 溶剂科学参考文献(芝加哥作者-日期格式)——点击展开

11种溶剂 × 5个独立科学来源(NIST/CRC/IARC/Hansen/Reichardt/Smallwood/Wypych/Armarego/Snyder/GESTIS)。下方55+完整引用。

Water (H₂O)
  1. NIST — NIST Chemistry WebBook — Water (CAS 7732-18-5)
  2. CRC — CRC Handbook of Chemistry and Physics, 104th ed., Sec. 8 (Properties of Water)
  3. IAPWS — IAPWS Release on Static Dielectric Constant of Water
  4. Reichardt 2011 — Solvents and Solvent Effects in Organic Chemistry
  5. GESTIS — GESTIS Substance Database — Water
Ethanol (EtOH)
  1. NIST — NIST Chemistry WebBook — Ethanol (CAS 64-17-5)
  2. CRC — CRC Handbook — Ethanol physical constants
  3. Snyder & Kirkland — Modern Liquid Chromatography — Ethanol eluotropic
  4. Smallwood — Handbook of Organic Solvent Properties — Ethanol
  5. GESTIS — GESTIS Substance Database — Ethanol
Methanol (MeOH)
  1. NIST — NIST Chemistry WebBook — Methanol (CAS 67-56-1)
  2. CRC — CRC Handbook — Methanol physical constants
  3. Snyder & Kirkland — Modern Liquid Chromatography — MeOH eluotropic, eo=0.95
  4. GESTIS — GESTIS Substance Database — Methanol
Acetone
  1. NIST — NIST Chemistry WebBook — Acetone (CAS 67-64-1)
  2. CRC — CRC Handbook — Acetone physical & thermodynamic constants
  3. Hansen 2007 — Hansen Solubility Parameters — Acetone (dD=15.5, dP=10.4, dH=7.0)
  4. Smallwood — Handbook of Organic Solvent Properties — Acetone
  5. GESTIS — GESTIS Substance Database — Acetone
Acetonitrile (ACN)
  1. NIST — NIST Chemistry WebBook — Acetonitrile (CAS 75-05-8)
  2. CRC — CRC Handbook — Acetonitrile constants
  3. Snyder & Kirkland — Modern Liquid Chromatography — ACN gold-standard HPLC eluent
  4. Reichardt 2011 — Solvents and Solvent Effects — ACN dipolar aprotic
  5. GESTIS — GESTIS Substance Database — Acetonitrile
DMSO
  1. NIST — NIST Chemistry WebBook — DMSO (CAS 67-68-5)
  2. Wypych 2019 — Handbook of Solvents Vol. 1 — DMSO comprehensive properties
  3. Hansen 2007 — HSP — DMSO (dD=18.4, dP=16.4, dH=10.2)
  4. Reichardt 2011 — Solvents and Solvent Effects — DMSO E_T(30)=45.1, dipolar aprotic
  5. GESTIS — GESTIS Substance Database — DMSO
THF
  1. NIST — NIST Chemistry WebBook — THF (CAS 109-99-9)
  2. Armarego 2009 — Purification of Laboratory Chemicals — THF drying & peroxide test
  3. Hansen 2007 — Hansen Solubility Parameters — THF (dD=16.8, dP=5.7, dH=8.0)
  4. Smallwood — Handbook of Organic Solvent Properties — THF
  5. GESTIS — GESTIS Substance Database — Tetrahydrofuran
DCM (CH₂Cl₂)
  1. NIST — NIST Chemistry WebBook — Dichloromethane (CAS 75-09-2)
  2. IARC 71 — IARC Monograph 71 — DCM (Group 2A carcinogen)
  3. Hansen 2007 — Hansen Solubility Parameters — DCM (dD=18.2, dP=6.3, dH=6.1)
  4. Reichardt 2011 — Solvents and Solvent Effects — DCM polarity index
  5. GESTIS — GESTIS Substance Database — Dichloromethane
Chloroform (CHCl₃)
  1. NIST — NIST Chemistry WebBook — Chloroform (CAS 67-66-3)
  2. IARC 73 — IARC Monograph 73 — Chloroform (Group 2B carcinogen)
  3. Hansen 2007 — Hansen Solubility Parameters — CHCl3 (dD=17.8, dP=3.1, dH=5.7)
  4. Reichardt 2011 — Solvents and Solvent Effects — CHCl3 H-bond donor strength
  5. GESTIS — GESTIS Substance Database — Chloroform
n-Hexane
  1. NIST — NIST Chemistry WebBook — n-Hexane (CAS 110-54-3)
  2. ATSDR n-Hexane — ATSDR Toxicological Profile for n-Hexane — neuropatia obwodowa (n-Heksan NIE jest kancerogenem IARC)
  3. Hansen 2007 — Hansen Solubility Parameters — n-Hexane (dD=14.9, dP=0, dH=0)
  4. Snyder & Kirkland — Modern Liquid Chromatography — n-Hexane NP standard, eo=0.00
  5. GESTIS — GESTIS Substance Database — n-Hexane
Toluene
  1. NIST — NIST Chemistry WebBook — Toluene (CAS 108-88-3)
  2. IARC 71 — IARC Monograph 71 — Toluene
  3. Hansen 2007 — Hansen Solubility Parameters — Toluene (dD=18.0, dP=1.4, dH=2.0)
  4. Smallwood — Handbook of Organic Solvent Properties — Toluene
  5. GESTIS — GESTIS Substance Database — Toluene
溶解性理论(应用于相容性预测):
  1. Yalkowsky, Samuel H., and Shri C. Valvani. 1980. "Solubility and Partitioning I: Solubility of Nonelectrolytes in Water." Journal of Pharmaceutical Sciences 69 (8): 912–922. https://doi.org/10.1002/jps.2600690814 — General Solubility Equation (GSE): logS = 0.5 − logP − 0.01(MP−25).
  2. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook. 2nd ed. CRC Press. https://doi.org/10.1201/9781420006834 — HSP三元组(dD, dP, dH)+ Ra公式。
  3. Stefanis, E., and C. Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." Int J Thermophys 29: 568–585. https://doi.org/10.1007/s10765-008-0415-z
  4. Reichardt, Christian, and Thomas Welton. 2011. Solvents and Solvent Effects in Organic Chemistry. 4th ed. Wiley-VCH. https://doi.org/10.1002/9783527632220 — E_T(30) polarity scale, solwatochromia.
  5. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley. https://doi.org/10.1002/9780470508183 — Eluotropic series, polarity index.
  6. Van Krevelen, D. W., and K. Te Nijenhuis. 2009. Properties of Polymers. 4th ed. Elsevier. https://doi.org/10.1016/B978-0-08-054819-7.X0001-5 — Hoftyzer–Van Krevelen group contribution dla dD/dP/dH z SMILES.
  7. Marcus, Yizhak. 1998. The Properties of Solvents. Wiley Series in Solution Chemistry, Vol. 4. ISBN 9780471983699 — 250+溶剂的完整表格数据集(ε、μ、供体数、受体数)。
  8. PubChem Compound Database — CAS 79-06-1 lookup ↗ — logP (XLogP3), water solubility experimental + predicted.

完整参考文献位于页面底部的参考文献折叠面板——芝加哥格式手册第17版作者-日期格式。

📚 技术FAQ — Acrylamide (5) MolGod_TECHFAQ_1
❓ Jak przygotować roztwór standardowy akrylamidu o stężeniu 10 mg/mL?
Aby przygotować roztwór standardowy akrylamidu (CAS 79-06-1) o stężeniu 10 mg/mL, należy odważyć 10 mg substancji (co odpowiada około 0.14 mol) i rozpuścić w 1 mL rozpuszczalnika (np. metanolu lub wody dejonizowanej). Masa akrylamidu potrzebna do przygotowania roztworu: masa = stężenie × objętość = 10 mg/mL × 1 mL = 10 mg. Wzór chemiczny: C3H5NO, masa molowa: 71.08 g/mol.
有帮助吗?
❓ Jak przechowywać akrylamid (CAS 79-06-1) w laboratorium?
Akrylamid należy przechowywać w szczelnie zamkniętych pojemnikach, w temperaturze 2-8°C, z dala od światła słonecznego i źródeł ciepła. Wilgotność względna powietrza nie powinna przekraczać 65%. Substancja jest higroskopijna, więc należy unikać kontaktu z wilgocią.
有帮助吗?
❓ Jaka metoda analityczna jest najlepsza do oznaczania akrylamidu w próbkach żywności?
Dla akrylamidu (logP nieokreślony, MW 71.08 g/mL) zalecana jest chromatografia cieczowa wysokosprawna (HPLC) z detektorem UV lub fluorescencyjnym. Metoda GC może być stosowana po odpowiedniej derywatyzacji próbki.
有帮助吗?
❓ Jakie są główne niezgodności chemiczne akrylamidu (CAS 79-06-1)?
Akrylamid reaguje z silnymi utleniaczami (np. nadtlenkiem wodoru) i zasadami (np. NaOH). Nie należy go przechowywać w obecności reduktorów lub kwasów organicznych, które mogą prowadzić do niepożądanych reakcji. Substancja jest również toksyczna i wymaga ostrożnego obchodzenia się.
有帮助吗?
❓ W jakich zastosowaniach laboratoryjnych wykorzystuje się akrylamid (CAS 79-06-1)?
Akrylamid jest stosowany jako monomer w produkcji poliakrylamidu, używanego w żelach elektroforetycznych do rozdziału białek i kwasów nukleinowych. W analizie chemicznej służy jako wzorzec do oznaczania zawartości w próbkach żywności i środowiskowych.
有帮助吗?
🧮 实验室计算器(8个) MolGod_LABCALC_1
稀释(C₁V₁=C₂V₂)
摩尔浓度(M=n/V)
pH缓冲液(Henderson-Hasselbalch)
Beer-Lambert(A=εcl)
质量→摩尔
浓度%→M
ppm→mg/L
温度 C↔F↔K

已验证的配方: IUPAC Gold Book ↗, DOI ↗

📊 光谱数据库 MolGod_SPECDB_3
📋 实验室方案生成器 MolGod_PROTOCOL_1

方案基于以下内容生成: GHS SDS, Aldrich Lab Guide ↗

🏷️ 标签生成器(QR码) MolGod_LABEL_1
丙烯酰胺• ACRYLAMIDE• CAS: 79-06-1• EC: 201-173-7• 分子式: C3H5NO• 摩尔质量: 71.08 g/mol危险GHS危险说明:DH ScientificScience first. Commerce as consequence.批号: 净含量: 生产日期:
ADMET — ADMET 性质

类药性雷达图(Lipinski Ro5 / Veber)。绿色区域 = 符合标准。

预测数据 — 通过计算机模拟(SMILES/RDKit)计算的属性。不能替代临床研究。未经实验验证,不得用于药物评估。

MW71.1LogP-0.7HBD1HBA1RotB1TPSA43.1 Ų
✓ Lipinski Ro5✓ Veber✓ Egan✗ Ghose (MW=71, LogP=-0.7)✗ REOS (MW=71)✓ Lead-like Ro3
属性值评级
吸收(GI)高✓
血脑屏障通透性是(可透过)
生物利用度(Daina 2017)
55%
CYP450概况CYP1A2 non-inhibitorCYP2C9 non-inhibitorCYP2C19 non-inhibitorCYP2D6 non-inhibitorCYP3A4 non-inhibitor
PAINS警告1⚠
Brenk警告1⚠
pKa (pH 7.4)9 (predicted)
hERG(心脏毒性)✓ 否
P-gp底物—
Ames致突变性✓ 否
DILI(肝毒性)—
LogS(水溶性)—
来源(ADMET方法学)
  1. Lipinski, Christopher A., Franco Lombardo, Beryl W. Dominy, and Paul J. Feeney. 1997. "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings." Advanced Drug Delivery Reviews 23 (1-3): 3-25.
  2. Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, et al. 2002. "Molecular properties that influence the oral bioavailability of drug candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
  3. Daina, Antoine, Olivier Michielin, and Vincent Zoete. 2017. "SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness." Scientific Reports 7: 42717.
  4. Egan, William J., and Gregory Lauri. 2002. "Prediction of intestinal permeability." Advanced Drug Delivery Reviews 54 (3): 273-289.
  5. Baell, Jonathan B., and Georgina A. Holloway. 2010. "New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries." Journal of Medicinal Chemistry 53 (7): 2719-2740.
  6. Brenk, Ruth, Alessandro Schipani, Daniel James, et al. 2008. "Lessons learnt from assembling screening libraries for drug discovery for neglected diseases." ChemMedChem 3 (3): 435-444.
  7. Ertl, Peter, and Ansgar Schuffenhauer. 2009. "Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions." Journal of Cheminformatics 1: 8.
  8. Bickerton, G. Richard, Gaia V. Paolini, Jérémy Besnard, Sorel Muresan, and Andrew L. Hopkins. 2012. "Quantifying the Chemical Beauty of Drugs." Nature Chemistry 4 (2): 90-98.
  9. Hopkins, Andrew L., and Colin R. Groom. 2002. "The Druggable Genome." Nature Reviews Drug Discovery 1 (9): 727-730.
  10. Ghose, Arup K., Vellarkad N. Viswanadhan, and John J. Wendoloski. 1999. "A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery." Journal of Combinatorial Chemistry 1 (1): 55-68.
  11. Tice, Raymond R., Christopher P. Austin, Robert J. Kavlock, and John R. Bucher. 2013. "Improving the Human Hazard Characterization of Chemicals: A Tox21 Update." Environmental Health Perspectives 121 (7): 756-765.
  12. Leeson, Paul D., and Brian Springthorpe. 2007. "The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry." Nature Reviews Drug Discovery 6 (11): 881-890.
  13. Hann, Michael M. 2011. "Molecular Obesity, Potency and Other Addictions in Drug Discovery." MedChemComm 2 (5): 349-355.
  14. Davies, Mark, Michał Nowotka, George Papadatos, et al. 2015. "ChEMBL Web Services: Streamlining Access to Drug Discovery Data and Utilities." Nucleic Acids Research 43 (W1): W612-W620.
  15. Walters, W. Patrick, and Mark A. Murcko. 2002. "Prediction of 'Drug-Likeness.'". Advanced Drug Delivery Reviews 54 (3): 255–271. https://doi.org/10.1016/S0169-409X(02)00003-0.
  16. Congreve, Miles, Robin Carr, Christopher Murray, and Harren Jhoti. 2003. "A 'Rule of Three' for Fragment-Based Lead Discovery?" Drug Discovery Today 8 (19): 876–877. https://doi.org/10.1016/S1359-6446(03)02831-9.
  17. Brenk, Ruth, Alessandro Schipani, Daniel James, Agata Krasowski, Iain Hugh Gilbert, Julie Frearson, and Paul Graham Wyatt. 2008. "Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases." ChemMedChem 3 (3): 435-444.
  18. Schomburg, Karen T., Sascha Bietz, Hans Briem, Andrea M. Henzler, Stefan Urbaczek, and Matthias Rarey. 2014. "Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening." Journal of Chemical Information and Modeling 54 (6): 1676-1686.
  19. Bemis, Guy W., and Mark A. Murcko. 1996. "The Properties of Known Drugs. 1. Molecular Frameworks." Journal of Medicinal Chemistry 39 (15): 2887-2893.
  20. Schomburg, Karen T., and Matthias Rarey. 2014. "What Is the Potential of Structure-Based Target Prediction Methods?" Future Medicinal Chemistry 6 (17): 1987-1989.
  21. Jackson, Paul A., John C. Widen, Daniel A. Harki, and Kay M. Brummond. 2017. "Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions." Journal of Medicinal Chemistry 60 (3): 839-885. ↗
  22. Jackson, Paul A., et al. 2017. "Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions." Journal of Medicinal Chemistry 60 (3): 839-885. ↗
  23. Jong‐Su Park, Palas Samanta, Sangwoo Lee et al.. (2021). "Developmental and Neurotoxicity of Acrylamide to Zebrafish". International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22073518
  24. Melissa Faria, Tamar Ziv, Cristian Gómez‐Canela et al.. (2018). "Acrylamide acute neurotoxicity in adult zebrafish". Scientific Reports. https://doi.org/10.1038/s41598-018-26343-2
  25. N. Muttucumaru, Stephen J. Powers, J. Stephen Elmore et al.. (2016). "Acrylamide-forming potential of potatoes grown at different locations, and the ratio of free asparagine to reducing sugars at which free asparagine becomes a limiting factor for acrylamide formation". Food Chemistry. https://doi.org/10.1016/j.foodchem.2016.09.199
  26. (2012). "Toxicology and carcinogenesis studies of acrylamide (CASRN 79-06-1) in F344/N rats and B6C3F1 mice (feed and drinking water studies).". PubMed.
  27. Claudio Pelucchi, Carlo La Vecchia, Cristina Bosetti et al.. (2011). "Exposure to acrylamide and human cancer—a review and meta-analysis of epidemiologic studies". Annals of Oncology. https://doi.org/10.1093/annonc/mdq610
  28. European Food Safety Authority. (2011). "Results on acrylamide levels in food from monitoring years 2007–2009 and Exposure assessment". EFSA Journal. https://doi.org/10.2903/j.efsa.2011.2133
  29. Burhan I. Ghanayem, Re Bai, Grace E. Kissling et al.. (2009). "Diet-Induced Obesity in Male Mice Is Associated with Reduced Fertility and Potentiation of Acrylamide-Induced Reproductive Toxicity1". Biology of Reproduction. https://doi.org/10.1095/biolreprod.109.078915
  30. Sean M. Hays, Lesa L. Aylward. (2008). "Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1)". Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2008.05.010
  31. Skott, A., Hofmann, A., Sorgel, F. et al.. (2002). "Acrylamide: Increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans". https://doi.org/10.1159/000069715
  32. Lawrence, Justin R., O\u27Neill, Feidhlim T., O'Neill, Feidhlim T. et al.. (2001). "Thickness variation of self-processing acrylamide-based photopolymer and reflection holography". https://doi.org/10.1117/1.1353801
  33. (0). "NIOSH skin notation profile : acrylamide [CAS No. 79-06-1]".
  34. et al. 2026. "Design and synthesis of carbazole-acrylamide-pyridinium hybrids as dual acetylcholinesterase/butyrylcholinesterase inhibitors and evaluation of their cytotoxic profile on SH-SY5Y and HEK293 cell lines." DOI: 10.1039/d5md01075f. [DOI ↗]
  35. et al. 2026. "Design, Synthesis, and Cytotoxic Evaluation of <i>N</i>-Phenyl-3-(Thiophen-2-Yl)acrylamide Derivatives." DOI: 10.3390/molecules31183147. [DOI ↗]
  36. et al. 2026. "Processing-Dependent Acrylamide Formation in French Fries: Optimisation of QuEChERS-Based Extraction and HPLC-PDA Determination." DOI: 10.3390/molecules31162777. [DOI ↗]
  37. et al. 2026. "Corncob-Derived Xylo-Oligosaccharides Attenuate Acrylamide-Induced Gut-Liver Toxicity in Mice, Associated with Modulation of Gut Microbiota and SCFA Metabolism." DOI: 10.3390/biology15191684. [DOI ↗]
  38. Kocadağlı, Tolgahan; Gökmen, Vural. 2024. "Metabolism of acrylamide in humans and biomarkers of exposure to acrylamide." Acrylamide in Food. DOI: 10.1016/b978-0-323-99119-3.00010-2. [DOI ↗]
  39. Kocadağlı, Tolgahan, Gökmen, Vural. 2024. "Metabolism of acrylamide in humans and biomarkers of exposure to acrylamide." Acrylamide in Food: 111-129. https://doi.org/10.1016/b978-0-323-99119-3.00010-2. [DOI ↗]
  40. 2018. "Acrylamide and Processed Potatoes." Grow: Plant Health Exchange. DOI: 10.1094/grow-pot-11-18-077. [DOI ↗]
  41. Kocadağlı, Tolgahan; Gökmen, Vural. 2016. "Metabolism of Acrylamide in Humans and Biomarkers of Exposure to Acrylamide." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00006-1. [DOI ↗]
  42. Anese, Monica. 2016. "Acrylamide in Coffee and Coffee Substitutes." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00009-7. [DOI ↗]
  43. Mojska, Hanna. 2016. "Secular Trends in Food Acrylamide." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00003-6. [DOI ↗]
  44. Tepe, Yalçın. 2016. "Acrylamide in Surface and Drinking Water." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00014-0. [DOI ↗]
  45. Kocadağlı, Tolgahan, Gökmen, Vural. 2016. "Metabolism of Acrylamide in Humans and Biomarkers of Exposure to Acrylamide." Acrylamide in Food: 109-128. https://doi.org/10.1016/b978-0-12-802832-2.00006-1. [DOI ↗]
  46. Raloff, Janet. 2002. "Cooking up a carcinogen: Should we worry about all that acrylamide in our diet?." Science News 162 (8): 120-121. https://doi.org/10.2307/4013720. [DOI ↗]
  47. Anonymous. 1966. "now all the acrylamide you can handle." Chemical & Engineering News Archive 44 (20): 67. https://doi.org/10.1021/cen-v044n020.p067. [DOI ↗]
  48. "Acrylamide." DOI: 10.31003/uspnf_r8081_02_01. [DOI ↗]
  49. "Heat-Introduced Formation of Acrylamide in Table Olives: Analysis of Acrylamide, Free Asparagine, and 3Aminopropionamide." DOI: 10.1021/acs.jafc.3c03457.s001. [DOI ↗]
  50. Anonymous. "Preparation and Cross-Linking of All-Acrylamide Diblock Copolymer Nano-Objects via Polymerization-Induced Self-Assembly in Aqueous Solution.". https://doi.org/10.1021/acs.macromol.6b02643.s001. [DOI ↗]
  51. et al. 2026. "Design, characterization, DFT studies, and molecular docking of new benzofuran-pyrazol-acrylamide hybrids as insecticidal agents against Spodoptera littoralis and Tribolium castaneum." DOI: 10.1038/s41598-026-39839-z. [DOI ↗]
  52. et al. 2026. "Acrylamide-Induced Neurotoxicity Is Mitigated by Curcumin and Its Nano Lipid Carrier Formulation in Albino Rats." DOI: 10.1002/tox.70043. [DOI ↗]
  53. et al. 2026. "ATRA-mediated RAR-α activation attenuates acrylamide-induced testicular toxicity." DOI: 10.1038/s41598-026-50168-z. [DOI ↗]
  54. et al. 2026. "AC Electrokinetics-Enhanced Capacitive Aptasensor for Point-of-Care Testing of Acrylamide in Coffee." DOI: 10.3390/mi17080966. [DOI ↗]
  55. 2026. "Acrylamide-Induced Developmental and Molecular Toxicity in Drosophila melanogaster: The Role of Vanillic Acid in CncC/Keap1 Modulation." DOI: 10.1002/jbt.71088. [DOI ↗]
  56. Bolton, Evan E., Yanli Wang, Paul A. Thiessen, and Stephen H. Bryant. 2008. "PubChem: Integrated Platform of Small Molecules and Biological Activities." Annual Reports in Computational Chemistry 4: 217-241. [DOI ↗]
  57. Kim, Sunghwan, Jie Chen, Tiejun Cheng, et al. 2023. "PubChem 2023 update." Nucleic Acids Research 51 (D1): D1373-D1380. [DOI ↗]
  58. Kim, Sunghwan, Tiejun Cheng, Jianyong He, Chen Cheng, et al. 2021. "PubChem Protein, Pathway, Reaction, and Disease Specifications." Journal of Cheminformatics 13: 16. [DOI ↗]
  59. Hähnke, Volker D., Sunghwan Kim, and Evan E. Bolton. 2018. "PubChem chemical structure standardization." Journal of Cheminformatics 10: 36. [DOI ↗]
  60. Wang, Yanli, Stephen H. Bryant, Tiejun Cheng, Jiyao Wang, et al. 2017. "PubChem BioAssay: 2017 update." Nucleic Acids Research 45 (D1): D955-D963. [DOI ↗]
  61. Cheng, Tiejun, et al. 2014. "Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge." Journal of Chemical Information and Modeling 54 (3): 793-805. [DOI ↗]
  62. 2021. "HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators." DOI: 10.6019/CHEMBL4808148. [ChEMBL bioactivity primary lit] [DOI ↗]
  63. PubMed PMID PubChem. (Metadata fetch failed.) ↗
  64. et al. 2026. "Investigation of the effects of acrylamide on tendon healing in rats." DOI: 10.5152/j.aott.2026.25781. [DOI ↗]
  65. et al. 2026. "Mechanism-guided mitigation of acrylamide in thermally processed foods: emerging technologies and analytical verification." DOI: 10.3389/fnut.2026.1981497. [DOI ↗]
  66. 2025. "Purification of vegetable oils from acrylamide pollutants using metal-organic frameworks." DOI: 10.1038/s41598-025-28117-z. [DOI ↗]
  67. Wilkinson, Mark D., et al. 2016. "The FAIR Guiding Principles for scientific data management and stewardship." Scientific Data 3: 160018. [DOI ↗]
  68. Hersey, Anne, et al. 2015. "Chemical databases: curation or integration by user-defined equivalence?" Drug Discovery Today: Technologies 14: 17-24.
  69. Mendel Friedman. 2005. "Chemistry and safety of acrylamide in food." Springer. ↗
  70. United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Environmental Medicine. 2009. "Acrylamide." Agency for Toxic Substances Disease Registry, Division of Toxicology and Environmental Medicine, Dept. of Health and Human Services, Public Health Service. ↗
  71. Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, Brian R. Smith, Keith W. Ward, and Kenneth D. Kopple. 2002. "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
  72. Levitt, David. 2024. "Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids." ADMET and DMPK. https://doi.org/10.5599/admet.2414. [DOI ↗]
  73. Notario, Dion, Munzir, Angela Marietha, Novella, Yulina, Hananta, Linawati. 2024. "Impact of lactoferrin supplementation on cotrimoxazole pharmacokinetics: A preliminary clinical investigation." ADMET and DMPK. https://doi.org/10.5599/admet.2358. [DOI ↗]
  74. ECHA. 2024. "REACH Guidance." European Chemicals Agency. ↗
  75. Sridharan, Kannan, Al Banna, Rashed, Husain, Aysha. 2021. "Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model." ADMET and DMPK. https://doi.org/10.5599/admet.909. [DOI ↗]
  76. Cabana, Bernard E.. 1984. "Bioavailability and Pharmacokinetics in Drug Development." Pharmacokinetics: 113-132. https://doi.org/10.1007/978-1-4613-2799-8_12. [DOI ↗]
  77. Groom, Colin R., Ian J. Bruno, Matthew P. Lightfoot, and Suzanna C. Ward. 2016. "The Cambridge Structural Database." Acta Crystallographica Section B 72 (2): 171-179. ↗
🧪 溶液配制助手(Smart Prep) MolGod_PREP_2

输入您要制备的内容——我将生成SOP

示例如下——点击插入:
预设配方:
📚 科学文献概览 — CAS 79-06-1MolGod_LITHUB_MAIN
⭐ 关键发现(科学文献) 20 出版物
🏆 CAS 79-06-1 — multi-criteria ranking (W12): 30%引用·20%近期性·20%主题·15%历史·15%开放获取.
  1. #1
    et al. (2026) · Scientific Reports
    重要性: 近期(2026) · open access
    SCORE 10.08 机制 引用次数: 2 Open Access DOI ↗ PubMed ↗
  2. #2
    et al. (2026) · Frontiers in Nutrition
    重要性: 近期(2026) · open access
    SCORE 8.65 机制 Open Access DOI ↗ PubMed ↗
  3. #3
    et al. (2026) · Molecules
    重要性: 近期(2026) · open access
    SCORE 8.65 机制 Open Access DOI ↗ PubMed ↗
  4. #4
    Reda M. Abdelhameed; Randa S. Hasan; Hassan Abdel-Gawad (2025) · Scientific Reports
    重要性: 近期(2025) · open access
    SCORE 7.95 工业 引用次数: 1 Open Access DOI ↗ PubMed ↗
  5. #5
    et al. (2026) · Biology
    重要性: 近期(2026) · open access
    SCORE 7.85 药理学 Open Access DOI ↗ PubMed ↗
  6. #6
    et al. (2026) · Micromachines
    重要性: 近期(2026) · open access
    SCORE 7.85 机制 Open Access DOI ↗ PubMed ↗
  7. #7
    et al. (2026) · Environmental Toxicology
    重要性: 近期(2026) · open access
    SCORE 7.15 药理学 引用次数: 1 Open Access DOI ↗ PubMed ↗
  8. #8
    et al. (2026) · Molecules
    重要性: 近期(2026) · open access
    SCORE 7.05 机制 Open Access DOI ↗ PubMed ↗
  9. #9
    et al. (2026) · RSC Medicinal Chemistry
    重要性: 近期(2026) · open access
    SCORE 7.05 机制 Open Access DOI ↗ PubMed ↗
  10. #10
    et al. (2026) · Acta Orthopaedica et Traumatologica Turcica
    重要性: 近期(2026) · open access
    SCORE 7.05 工业 Open Access DOI ↗ PubMed ↗
  11. #11
    et al. (2026) · Scientific Reports
    重要性: 近期(2026) · open access
    SCORE 7.05 机制 Open Access DOI ↗ PubMed ↗
  12. #12
    Fahriye Zemheri‐Navruz; Sinan Ince; Gamze Ataman (2026) · Journal of Biochemical and Molecular Toxicology
    重要性: 近期(2026) · open access
    SCORE 7.05 药理学 Open Access DOI ↗ PubMed ↗
  13. #13
    et al. (2026) · Gels
    重要性: 近期(2026) · open access
    SCORE 7.05 机制 Open Access DOI ↗ PubMed ↗
  14. #14
    Eman M.S. Shaheen; Marwa A. E. Abd El‐Maksoud (2026) · Journal of Biochemical and Molecular Toxicology
    重要性: 近期(2026) · open access
    SCORE 7.05 药理学 Open Access DOI ↗ PubMed ↗
  15. #15
    Milan Mandal; Seth Agrippa Oppong; Keka Ojha (2026) · ACS Omega
    重要性: 近期(2026) · open access
    SCORE 7.05 机制 Open Access DOI ↗ PubMed ↗
  16. #16
    J. Wojciechowska-Puchałka, E. Drąg-Kozak, K. Kustra et al. (2026) · Poultry Science
    重要性: 近期(2026) · open access
    SCORE 7.05 机制 Open Access DOI ↗
  17. #17
    Ghanayem BI; Bai R; Kissling GE et al. (2010) · Biology of reproduction
    重要性: 必引文献(经典) · 131次引用
    SCORE 6.36 机制 MUST-CITE 引用次数: 131 DOI ↗
  18. #18
    et al. (2026) · BMC Pharmacology and Toxicology
    重要性: 近期(2026) · open access
    SCORE 6.25 药理学 Open Access DOI ↗ PubMed ↗
  19. #19
    Seyed Jamaleddin Peighambardoust, Hamzeh Khatooni, Naeimeh Sadat Peighambardoust (2026) · Scientific Reports
    重要性: 近期(2026) · open access
    SCORE 6.25 机制 Open Access DOI ↗
  20. #20
    Damian Chandia-Poblete, Stéphane Tuffier, Efstathios Vryonidis et al. (2026) · EClinicalMedicine
    重要性: 近期(2026) · open access
    SCORE 6.25 机制 Open Access DOI ↗
📈 HPLC梯度——优化器(LSS) 模板

基于PubChem XLogP3 + LSS(Snyder等人,2010,第9章)的梯度。

  • 色谱柱: C18
  • 缓冲液: phosphate
  • 流速: 1 mL/min
  • logP: -0.7 (PubChem XLogP3)
  • 斜率: 5% → 95% B, 10 min
  • 总分析时间: 23 min
t (min) %A %B flow (mL/min) 备注
0 95 5 1 开始(平衡)
2 95 5 1 初始保持结束
12 5 95 1 LSS 梯度结束
17 5 95 1 色谱柱清洗
18 95 5 1 返回初始条件
23 95 5 1 再平衡
📚 科学参考文献(芝加哥作者-日期格式)
  1. Snyder, Lloyd R., John W. Dolan, and Joseph J. Kirkland. 2010. Introduction to Modern Liquid Chromatography. Wiley. — Chapter 9 — gradient elution, LSS theory (cited as Snyder et al. 2010 in tool description).
  2. Schoenmakers, Peter J. 1986. Optimization of Chromatographic Selectivity: A Guide to Method Development. Elsevier. — Numerical optimization of gradient programs.
  3. Snyder, L. R., and J. W. Dolan. 2007. High-Performance Gradient Elution: The Practical Application of the Linear-Solvent-Strength Model. Wiley. — Foundational LSS reference for the %B_init = 5 + 8·logP heuristic implemented here.
  4. Nikitas, Pavlos, and Adrian Pappa-Louisi. 2009. "Retention models for isocratic and gradient elution in reversed-phase liquid chromatography." Journal of Chromatography A 1216: 1737-1755. [DOI ↗] — Modern review of gradient retention models — basis for non-LSS extensions.
  5. Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772. [DOI ↗]
  6. Dong, Michael W. 2019. HPLC and UHPLC for Practicing Scientists. Wiley. https://doi.org/10.1002/9781119313793. — Modern UHPLC gradient programming, sub-2 µm scaling rules.
  7. Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." Journal of Separation Science 30: 1167-1182. [DOI ↗]
  8. Stoll, Dwight R., and Peter W. Carr. 2017. "Two-Dimensional Liquid Chromatography: A State of the Art Tutorial." Analytical Chemistry 89: 519-531. [DOI ↗] — Reference for orthogonal gradient design (2D-LC second dimension).
  9. Dolan, John W.. 2013. "When to Modify Method Conditions." LCGC North America 31: 192-199.
  10. Meyer, Veronika R. 2010. Practical High-Performance Liquid Chromatography. Wiley. — Chapter 7 — practical gradient design with isokratyczny scouting.
  11. Stoll, Dwight R., and Peter W. Carr. 2017. "Two-Dimensional Liquid Chromatography: A State of the Art Tutorial." Analytical Chemistry 89: 519-531. [DOI ↗]
  12. Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772. [DOI ↗]
  13. Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." Journal of Separation Science 30: 1167-1182. [DOI ↗]
  14. Engelhardt, Heinz. 2014. 100 Years of Chromatography. Wiley-VCH.
  15. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." Analytical Chemistry 82: 8525-8531. [DOI ↗]

REST: /wp-json/molgod/v1/hplc/gradient/79-06-1

📐 HPLC峰对称性计算器(USP Tf / As)

根据峰半宽计算USP拖尾因子(Tf)和不对称度(As)。输入在峰高5%或10%处测量的a(左半宽)和b(右半宽)。

📚 参考文献(芝加哥作者-日期格式)
  1. USP General Chapter <621>. 2024. "Chromatography." United States Pharmacopeial Convention. [link ↗] — Defines USP Tailing Factor T = (a+b)/(2a) measured at 5% peak height.
  2. International Council for Harmonisation (ICH). 2023. "Validation of Analytical Procedures Q2(R2)." ICH Expert Working Group. [link ↗] — Tailing factor is a system suitability parameter (Section 6).
  3. Foley, Joe P., and John G. Dorsey. 1983. "Equations for calculation of chromatographic figures of merit for ideal and skewed peaks." Analytical Chemistry 55: 730-737 https://doi.org/10.1021/ac00255a033 [link ↗] — Original asymmetry factor As = b/a at 10% height (Foley & Dorsey 1983).
  4. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." Wiley. https://doi.org/10.1002/9780470508183 [link ↗] — Chapter 2.4 — peak shape diagnostics and remedies.
  5. Dolan, John W.. 2003. "Peak tailing and resolution." LCGC North America 21: 610-614 [link ↗] — How tailing factor degrades effective resolution.
  6. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." Analytical Chemistry 82: 8525-8531 https://doi.org/10.1021/ac101742z [link ↗] — Modern numerical deconvolution for asymmetric peaks.
  7. Kromidas, Stavros. 2017. "HPLC Made to Measure: A Practical Handbook for Optimization." Wiley-VCH. — Practical Tf and As thresholds for routine QC.
  8. Dong, Michael W.. 2019. "HPLC and UHPLC for Practicing Scientists." Wiley. https://doi.org/10.1002/9781119313793 [link ↗]
  9. Meyer, Veronika R.. 2010. "Practical High-Performance Liquid Chromatography." Wiley.
  10. Heyden, Yvan Vander, et al.. 2009. "Robustness of pharmaceutical liquid chromatographic methods." Journal of Chromatography B 877: 2120-2129 https://doi.org/10.1016/j.jchromb.2008.10.052 [link ↗]
  11. Stoll, Dwight R., and Peter W. Carr. 2017. "Two-Dimensional Liquid Chromatography: A State of the Art Tutorial." Analytical Chemistry 89: 519-531 https://doi.org/10.1021/acs.analchem.6b03506 [link ↗]
  12. Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772 https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗]
  13. Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." Journal of Separation Science 30: 1167-1182 https://doi.org/10.1002/jssc.200700026 [link ↗]
  14. Engelhardt, Heinz. 2014. "100 Years of Chromatography." Wiley-VCH.
  15. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." Analytical Chemistry 82: 8525-8531 https://doi.org/10.1021/ac101742z [link ↗]
📊 分辨率和塔板数计算器(Rs, N, H)

计算一对HPLC峰的分辨率Rs、理论塔板数N和HETP(H)。输入保留时间、峰宽(在50%或基线处)和色谱柱长度。

📚 参考文献(芝加哥作者-日期格式)
  1. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." 3rd ed. John Wiley & Sons. ISBN 978-0-470-16754-0. https://doi.org/10.1002/9780470508183 [link ↗] — Chapter 2 covers resolution, plate count and HETP fundamentals (Snyder et al. 2010).
  2. USP General Chapter <621>. 2024. "Chromatography." USP-NF 2024 ed. United States Pharmacopeial Convention. [link ↗] — Defines Rs >= 1.5 acceptance criterion and N calculation methods.
  3. Dolan, John W.. 2003. "How much resolution is enough?." LCGC North America 21: 350-353 [link ↗] — Practical guidance on Rs targets for routine method development.
  4. Van Deemter, J. J., F. J. Zuiderweg, and A. Klinkenberg. 1956. "Longitudinal diffusion and resistance to mass transfer as causes of nonideality in chromatography." Chemical Engineering Science 5: 271-289 https://doi.org/10.1016/0009-2509(56)80003-1 [link ↗] — Origin of N = 5.54·(tr/w0.5)² half-height plate count formulation.
  5. Giddings, J. Calvin. 1965. "Dynamics of Chromatography, Part I: Principles and Theory." Marcel Dekker. ISBN 978-0-8247-1357-7. — Resolution equation Rs = (1/4)·√N·(α-1)/α·k/(1+k) (master equation).
  6. Foley, Joe P., and John G. Dorsey. 1983. "Equations for calculation of chromatographic figures of merit for ideal and skewed peaks." Analytical Chemistry 55: 730-737 https://doi.org/10.1021/ac00255a033 [link ↗] — Skewed-peak corrections to apparent N.
  7. Knox, John H.. 1977. "Practical aspects of LC theory." Journal of Chromatographic Science 15: 352-364 https://doi.org/10.1093/chromsci/15.9.352 [link ↗]
  8. Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772 https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗]
  9. Dong, Michael W.. 2019. "HPLC and UHPLC for Practicing Scientists." 2nd ed. Wiley. ISBN 978-1-119-31378-3. https://doi.org/10.1002/9781119313793 [link ↗]
  10. Meyer, Veronika R.. 2010. "Practical High-Performance Liquid Chromatography." 5th ed. Wiley. ISBN 978-0-470-68218-0.
  11. Stoll, Dwight R., and Peter W. Carr. 2017. "Two-Dimensional Liquid Chromatography: A State of the Art Tutorial." Analytical Chemistry 89: 519-531 https://doi.org/10.1021/acs.analchem.6b03506 [link ↗]
  12. Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772 https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗]
  13. Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." Journal of Separation Science 30: 1167-1182 https://doi.org/10.1002/jssc.200700026 [link ↗]
  14. Engelhardt, Heinz. 2014. "100 Years of Chromatography." 2nd ed. Wiley-VCH. ISBN 978-3-527-33473-5.
  15. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." Analytical Chemistry 82: 8525-8531 https://doi.org/10.1021/ac101742z [link ↗]
🧪 系统适用性——实时计算器(USP <621>)

输入5-6次进样的数据(峰面积、保留时间、拖尾因子、塔板数)——计算器将计算%RSD和平均值,并检查是否符合USP <621>。您可以粘贴CSV(逗号分隔)或编辑单个值。

📚 参考文献(芝加哥作者-日期格式)
  1. USP General Chapter <621>. 2024. "Chromatography (System Suitability section)." USP-NF 2024 ed. United States Pharmacopeial Convention. [link ↗] — Defines RSD area < 2%, tailing < 2.0, N > 2000 acceptance criteria.
  2. International Council for Harmonisation (ICH). 2023. "Validation of Analytical Procedures Q2(R2)." ICH Expert Working Group. [link ↗] — Section 5.4 — system suitability is part of method validation.
  3. US Food and Drug Administration (FDA). 2018. "Reviewer Guidance: Validation of Chromatographic Methods." US Food and Drug Administration. [link ↗] — CDER reviewer perspective on chromatographic validation expectations.
  4. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." 3rd ed. Wiley. — Chapter 2 — system suitability fundamentals (RSD, Tf, N).
  5. Heyden, Yvan Vander, et al.. 2009. "Robustness of pharmaceutical liquid chromatographic methods." — Robustness vs. system suitability — design-of-experiments framework.
  6. Rozet, Eric, et al.. 2013. "Analysis of recent pharmaceutical regulatory documents on analytical method validation."
  7. European Medicines Agency (EMA). 2011. "Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009." EMA. [link ↗] — EMA companion guideline with bioanalytical SS criteria.
  8. Dong, Michael W.. 2019. "HPLC and UHPLC for Practicing Scientists." 2nd ed. Wiley. — UHPLC-specific suitability adjustments (n=5 vs. n=6).
  9. Kazakevich, Yuri V., and Rosario LoBrutto, eds.. 2007. "HPLC for Pharmaceutical Scientists." Wiley-Interscience.
  10. AOAC International. 2016. "Appendix F: Guidelines for Standard Method Performance Requirements." AOAC INTERNATIONAL. [link ↗] — Alternative SS thresholds for food/dietary samples.
  11. Stoll, Dwight R., and Peter W. Carr. 2017. "Two-Dimensional Liquid Chromatography: A State of the Art Tutorial."
  12. Carr, Peter W.. 2009. "The new physical chemistry of HPLC."
  13. Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations."
  14. Engelhardt, Heinz. 2014. "100 Years of Chromatography." 2nd ed. Wiley-VCH.
  15. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography."
📋 Status prawny (REACH / TSCA / UK)MolGod_REG_2
JurysdykcjaListaStatusSunset
EUSVHClisted—
📤 将此分子嵌入您的网站

有博客、论坛或科学网站吗? 将交互式3D分子嵌入到您的网站上——每位读者都能看到它,下方还有指向我们商店的链接,他们可以在那里购买试剂。

🔗 HTML iframe代码 (最简单——随处可用)

复制并粘贴到您网站的HTML编辑器中:

根据您的布局调整 width 和 height。

⚙ WordPress Shortcode (适用于其他使用MOL-GOD的商店)

🌐 直接链接 (用于电子邮件、聊天、LinkedIn、Twitter)

LinkedIn Twitter/X Facebook
QR code CAS 79-06-1

📱 QR code (用于印刷在传单/标签/目录上)

将其放置在产品目录、瓶标或传单上。客户扫描后,即可在手机上看到3D分子,并附有指向您商店的链接。

⬇ 下载PNG

🖼 Open Graph image (用于社交媒体元标签)

分享链接时,Facebook/LinkedIn/Discord会自动获取图像预览:

Preview
📋 许可证: 嵌入内容保留反向链接至 DH Scientific (必需——商店是数据来源)。 化学数据来源于 PubChem (CC0 — 公共领域). 嵌入内容免费用于教育、商业和业余用途。
📚 参考文献(综合书目,芝加哥作者-日期格式) 107 条目

以上折叠面板中针对CAS号79-06-1引用的所有科学来源。格式: 《芝加哥格式手册》第17版,作者-日期系统.

🗄️ 科学数据库

  1. NIST. 2026. NIST Chemistry WebBook: CAS 79-06-1. Gaithersburg, MD: National Institute of Standards and Technology. https://webbook.nist.gov/cgi/cbook.cgi?ID=79-06-1. (Accessed 2026-11-12.)
  2. AIST. 2026. Spectral Database for Organic Compounds (SDBS): CAS 79-06-1. Tsukuba, Japan: National Institute of Advanced Industrial Science and Technology. https://sdbs.db.aist.go.jp/. (Accessed 2026-11-12.)
  3. PubChem. 2026. PubChem Compound Summary: CAS 79-06-1. Bethesda, MD: National Center for Biotechnology Information (NCBI), National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/#query=79-06-1. (Accessed 2026-11-12.)
  4. ECHA. 2026. C&L Inventory and REACH Registration: CAS 79-06-1. Helsinki: European Chemicals Agency. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp. (Accessed 2026-11-12.)

📐 标准/指南

  1. ICH. 2026. "ICH Harmonised Guideline: CAS 79-06-1." Geneva: International Council for Harmonisation. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf. (Accessed 2026-11-12.)
  2. National Fire Protection Association (NFPA). 2024. "NFPA 30: Flammable and Combustible Liquids Code." NFPA, Quincy, MA. https://www.nfpa.org/codes-and-standards/all-codes-and-standards/list-of-codes-and-standards/detail?code=30.
  3. Occupational Safety and Health Administration (OSHA). 2023. "29 CFR 1910.106 — Flammable Liquids." U.S. Department of Labor, Federal Register. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.106.
  4. European Chemicals Agency (ECHA). 2024. "Annex VI to Regulation (EC) No 1272/2008 (CLP) — Harmonised Classification and Labelling." ECHA, Helsinki / Official Journal of the European Union. https://echa.europa.eu/regulations/clp/clp-classification.
  5. European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms — Part 1: Terminology and performance requirements for chemical risks." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=205:110:::::FSP_PROJECT,FSP_ORG_ID:38536,6080&cs=1B0DAA8B85DF42E4A2C70E5D71F0BFA32.
  6. European Committee for Standardization (CEN). 2001. "EN 166:2001 — Personal eye-protection — Specifications." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:6541&cs=1F1A4E0A78C4DB6A28DBE2E8C29D89DCF.
  7. European Committee for Standardization (CEN). 2009. "EN 14605:2005+A1:2009 — Protective clothing against liquid chemicals — Performance requirements for clothing with liquid-tight (Type 3) or spray-tight (Type 4) connections." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:21581&cs=1A04A2D3C7CC58E9E6CB58D55F7EBFB7E.
  8. National Institute for Occupational Safety and Health (NIOSH). 2017. "Recommendations for Chemical Protective Clothing: A Companion to the NIOSH Pocket Guide." U.S. Department of Health & Human Services / CDC. https://www.cdc.gov/niosh/ncpc/default.html.
  9. Occupational Safety and Health Administration (OSHA). 2011. "Personal Protective Equipment — General requirements." U.S. Department of Labor — 29 CFR 1910.132. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.132.

📖 书籍

  1. Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook, 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/Hansen-Solubility-Parameters-A-Users-Handbook/Hansen/p/book/9780849372483.
  2. Barton, Allan F. M. 1991. CRC Handbook of Solubility Parameters and Other Cohesion Parameters: 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/CRC-Handbook-of-Solubility-Parameters-and-Other-Cohesion-Parameters/Barton/p/book/9780849301766.
  3. Connors, Kenneth A., Gordon L. Amidon, and Valentino J. Stella. 1986. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, 2nd ed.. New York: Wiley. https://doi.org/10.1002/0471734683.
  4. Rumble, John R., ed. 2019. CRC Handbook of Chemistry and Physics: 100th Edition. Boca Raton, FL: CRC Press. https://hbcp.chemnetbase.com/.
  5. Urben, Peter G. 2017. Bretherick's Handbook of Reactive Chemical Hazards, 8th Edition. Academic Press / Elsevier, Oxford. https://www.sciencedirect.com/book/9780081010594.

📘 专著

  1. IARC. 2026. IARC Monographs on the Identification of Carcinogenic Hazards to Humans: CAS 79-06-1. Lyon, France: International Agency for Research on Cancer, World Health Organization. https://monographs.iarc.who.int/list-of-classifications/. (Accessed 2026-11-12.)

📄 科学文章(同行评审)

  1. Stefanis, Emmanuel, and Costas Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." International Journal of Thermophysics 29: 568-585. https://doi.org/10.1007/s10765-008-0415-z.
  2. Stoll, Vincent S., and John S. Blanchard. 1990. "Buffers: Principles and Practice: In Methods in Enzymology, vol. 182." San Diego: Academic Press. https://doi.org/10.1016/0076-6879(90)82008-P.

🌐 网站

  1. ECHA. 2023. "Guidance on the Application of the CLP Criteria." European Chemicals Agency. https://echa.europa.eu/guidance-documents/guidance-on-clp.
  2. European Parliament. 2006. "Regulation (EC) No 1907/2006 (REACH)." Official Journal of the European Union L 396: 1–849.
  3. ECHA. 2023. "Candidate List of Substances of Very High Concern for Authorisation." European Chemicals Agency. https://echa.europa.eu/candidate-list-table.
  4. European Parliament. 2008. "Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures (CLP)." Official Journal of the European Union L 353: 1–1355.
  5. ECHA. 2017. "Guidance on the Compilation of Safety Data Sheets." Version 3.1. European Chemicals Agency. ECHA-17-G-01-EN. https://echa.europa.eu/documents/10162/23047722/sds_en.pdf.
  6. ECHA. 2022. "Restrictions Under REACH — Annex XVII." European Chemicals Agency. https://echa.europa.eu/substances-restricted-under-reach.
  7. United Nations. 2021. Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 9th revised ed. ST/SG/AC.10/30/Rev.9. New York and Geneva: United Nations. https://unece.org/ghs-rev9-2021.
  8. ECHA. 2020. "Understanding REACH." European Chemicals Agency. https://echa.europa.eu/regulations/reach/understanding-reach.
  9. U.S. OSHA. 2026. "Occupational Safety and Health Guidance: CAS 79-06-1." Washington, DC: U.S. Occupational Safety and Health Administration. https://www.osha.gov/hazwoper. (Accessed 2026-11-12.)
  10. National Fire Protection Association (2018) — NFPA 472: Standard for Competence of Responders to Hazardous Materials/Weapons of Mass Destruction Incidents https://www.nfpa.org/codes-and-standards/nfpa-472.
  11. European Union. 2026. "EUR-Lex Legal Database: CAS 79-06-1." Luxembourg: Publications Office of the European Union. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32012L0018. (Accessed 2026-11-12.)
  12. U.S. National Institute for Occupational Safety and Health (2024) — NIOSH Pocket Guide to Chemical Hazards https://www.cdc.gov/niosh/npg/.
  13. Snyder, Lloyd R., John W. Dolan, and Joseph J. Kirkland. 2010. Introduction to Modern Liquid Chromatography. Wiley.
  14. Schoenmakers, Peter J.. 1986. Optimization of Chromatographic Selectivity: A Guide to Method Development. Elsevier.
  15. Snyder, L. R., and J. W. Dolan. 2007. High-Performance Gradient Elution: The Practical Application of the Linear-Solvent-Strength Model. Wiley.
  16. Nikitas, Pavlos, and Adrian Pappa-Louisi. 2009. "Retention models for isocratic and gradient elution in reversed-phase liquid chromatography." Journal of Chromatography A 1216: 1737-1755. https://doi.org/10.1016/j.chroma.2008.10.005.
  17. Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094.
  18. Dong, Michael W.. 2019. HPLC and UHPLC for Practicing Scientists. Wiley. https://doi.org/10.1002/9781119313793.
  19. Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." Journal of Separation Science 30: 1167-1182. https://doi.org/10.1002/jssc.200700026.
  20. Dolan, John W.. 2013. "When to Modify Method Conditions." LCGC North America 31: 192-199. https://www.chromatographyonline.com/view/when-modify-method-conditions.
  21. Meyer, Veronika R.. 2010. Practical High-Performance Liquid Chromatography. Wiley.
  22. Engelhardt, Heinz. 2014. 100 Years of Chromatography. Wiley-VCH.
  23. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." Analytical Chemistry 82: 8525-8531. https://doi.org/10.1021/ac101742z.
  24. Van Deemter, J. J., F. J. Zuiderweg, and A. Klinkenberg. 1956. "Longitudinal diffusion and resistance to mass transfer as causes of nonideality in chromatography." https://doi.org/10.1016/0009-2509(56)80003-1.
  25. Giddings, J. Calvin. 1965. "Dynamics of Chromatography, Part I: Principles and Theory." Marcel Dekker.
  26. Poppe, Hans. 1997. "Some reflections on speed and efficiency of modern chromatographic methods." https://doi.org/10.1016/S0021-9673(97)00376-2.
  27. Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." https://doi.org/10.1002/jssc.200700026.
  28. Carr, Peter W.. 2009. "The new physical chemistry of HPLC." https://doi.org/10.1016/j.chroma.2008.11.094.
  29. Knox, John H.. 1977. "Practical aspects of LC theory." https://doi.org/10.1093/chromsci/15.9.352.
  30. Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. "Practical HPLC Method Development." Wiley.
  31. Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." https://doi.org/10.1021/ac101742z.
  32. Sadek, Paul C.. 2002. "The HPLC Solvent Guide." Wiley-Interscience.
  33. Snyder, L. R.. 1978. "Classification of the solvent properties of common liquids." https://doi.org/10.1093/chromsci/16.6.223.
  34. Reichardt, Christian, and Thomas Welton. 2010. "Solvents and Solvent Effects in Organic Chemistry." Wiley-VCH.
  35. Vailaya, Anant, and Csaba Horváth. 1998. "Retention thermodynamics in hydrophobic interaction chromatography." https://doi.org/10.1021/ie980212h.
  36. Krstulović, Andrea M., and Phyllis R. Brown. 1981. "Reversed-phase High-Performance Liquid Chromatography." Wiley.
  37. Boysen, Reinhard I., and Milton T. W. Hearn. 2009. "Multi-modal HPLC of proteins." https://doi.org/10.1093/chromsci/47.8.645.
  38. USP General Chapter <621>. 2024. "Chromatography." United States Pharmacopeial Convention. https://www.usp.org/harmonization-standards/pdg/general-chapters/chromatography.
  39. Foley, Joe P., and John G. Dorsey. 1983. "Equations for calculation of chromatographic figures of merit for ideal and skewed peaks." https://doi.org/10.1021/ac00255a033.
  40. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." Wiley. https://doi.org/10.1002/9780470508183.
  41. Dolan, John W.. 2003. "Peak tailing and resolution." https://www.chromatographyonline.com/view/peak-tailing-and-resolution.
  42. Kromidas, Stavros. 2017. "HPLC Made to Measure: A Practical Handbook for Optimization." Wiley-VCH.
  43. Heyden, Yvan Vander, et al.. 2009. "Robustness of pharmaceutical liquid chromatographic methods." https://doi.org/10.1016/j.jchromb.2008.10.052.
  44. United States Pharmacopeial Convention. 2024. "USP <621> Chromatography." In United States Pharmacopeia and National Formulary, USP 47-NF 42. Rockville, MD: USP. https://www.uspnf.com/.
  45. European Pharmacopoeia Commission. 2024. "2.2.46 Chromatographic Separation Techniques." In European Pharmacopoeia, 11th ed. Strasbourg: Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
  46. International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories." Geneva: ISO. https://www.iso.org/standard/66912.html.
  47. Kolthoff, Izaak Maurits, and Philip J. Elving, eds. 1978. Treatise on Analytical Chemistry, Part I: Theory and Practice. 2nd ed. New York: Wiley-Interscience.
  48. Skoog, Douglas A., F. James Holler, and Stanley R. Crouch. 2018. Principles of Instrumental Analysis. 7th ed. Boston: Cengage Learning.
  49. Christian, Gary D., Purnendu K. Dasgupta, and Kevin A. Schug. 2014. Analytical Chemistry. 7th ed. Hoboken, NJ: Wiley.
  50. EURACHEM/CITAC. 2012. "Quantifying Uncertainty in Analytical Measurement." 3rd ed. EURACHEM/CITAC Guide CG 4. https://www.eurachem.org/images/stories/Guides/pdf/QUAM2012_P1.pdf.
  51. Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." John Wiley & Sons. https://doi.org/10.1002/9780470508183.
  52. Dolan, John W.. 2003. "How much resolution is enough?." https://www.chromatographyonline.com/view/how-much-resolution-enough.
  53. USP General Chapter <621>. 2024. "Chromatography (System Suitability section)." United States Pharmacopeial Convention. https://www.usp.org/harmonization-standards/pdg/general-chapters/chromatography.
  54. U.S. FDA. 2026. "FDA Guidance and Resources: CAS 79-06-1." Silver Spring, MD: U.S. Food and Drug Administration. https://www.fda.gov/media/74954/download. (Accessed 2026-11-12.)
  55. Rozet, Eric, et al.. 2013. "Analysis of recent pharmaceutical regulatory documents on analytical method validation." https://doi.org/10.1016/j.chroma.2007.03.111.
  56. European Medicines Agency (EMA). 2011. "Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009." EMA. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf.
  57. Kazakevich, Yuri V., and Rosario LoBrutto, eds.. 2007. "HPLC for Pharmaceutical Scientists." Wiley-Interscience. https://doi.org/10.1002/9780470087954.
  58. AOAC International. 2016. "Appendix F: Guidelines for Standard Method Performance Requirements." AOAC INTERNATIONAL. https://www.aoac.org/wp-content/uploads/2019/08/app_f.pdf.
  59. International Organization for Standardization. 1994. "ISO 5725-2:1994 Accuracy (Trueness and Precision) of Measurement Methods and Results — Part 2: Basic Method for the Determination of Repeatability and Reproducibility of a Standard Measurement Method." Geneva: ISO. https://www.iso.org/standard/11834.html.
  60. Grubbs, Frank E. 1950. "Sample Criteria for Testing Outlying Observations." Annals of Mathematical Statistics 21 (1): 27–58.
  61. Dixon, Wilfrid J. 1950. "Analysis of Extreme Values." Annals of Mathematical Statistics 21 (4): 488–506.
  62. Snedecor, George W., and William G. Cochran. 1989. Statistical Methods. 8th ed. Ames, IA: Iowa State University Press.
  63. Student [William Sealy Gosset]. 1908. "The Probable Error of a Mean." Biometrika 6 (1): 1–25.
  64. International Organization for Standardization. 2005. "ISO 3534-1:2006 Statistics — Vocabulary and Symbols — Part 1: General Statistical Terms and Terms Used in Probability." Geneva: ISO. https://www.iso.org/standard/40145.html.
  65. Thompson, Michael, Stephen L. R. Ellison, and Roger Wood. 2002. "Harmonized Guidelines for Single-Laboratory Validation of Methods of Analysis." Pure and Applied Chemistry 74 (5): 835–855.
  66. United Nations Economic Commission for Europe. 2024. European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR), Applicable as from 1 January 2025 (ECE/TRANS/352). Geneva: UNECE. https://unece.org/transport/dangerous-goods/adr-2025-edition.
  67. International Air Transport Association. 2026. Dangerous Goods Regulations (DGR). 67th ed. Montreal: IATA. https://www.iata.org/en/programs/cargo/dgr/.
  68. International Maritime Organization. 2024. International Maritime Dangerous Goods (IMDG) Code, 2024 Edition (Amendment 42-24). London: IMO. https://www.imo.org/en/OurWork/Safety/Pages/DangerousGoods-default.aspx.
  69. United Nations. 2025. Recommendations on the Transport of Dangerous Goods: Model Regulations (Orange Book). 24th revised ed. ST/SG/AC.10/1/Rev.24. New York and Geneva: United Nations. https://unece.org/transport/dangerous-goods/un-model-regulations.
  70. International Civil Aviation Organization. 2025. Technical Instructions for the Safe Transport of Dangerous Goods by Air (Doc 9284). 2025–2026 ed. Montreal: ICAO. https://www.icao.int/safety/DangerousGoods/Pages/technical-instructions.aspx.
  71. United States Pharmacopeia (USP) Convention. 2024. "USP General Chapter <621> Chromatography." USP. https://www.usp.org/sites/default/files/usp/document/harmonization/gen-chapter/g05_pf_30_4_2004.pdf.
  72. European Medicines Agency (EMA). 2011. "Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009." EMA Committee for Medicinal Products for Human Use. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf.
  73. Sejm RP. 2026. "Internetowy System Aktow Prawnych (ISAP): CAS 79-06-1." Warszawa: Kancelaria Sejmu Rzeczypospolitej Polskiej. https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20200000010. (Accessed 2026-11-12.)
  74. Ministerstwo Klimatu i Srodowiska. 2026. "Baza Danych o Odpadach (BDO): CAS 79-06-1." Warszawa: Ministerstwo Klimatu i Srodowiska. https://bdo.mos.gov.pl/. (Accessed 2026-11-12.)
  75. Pohanish, Richard P.. 2017. "Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens." Elsevier.
  76. Lewis, Richard J.. 2012. "Sax's Dangerous Properties of Industrial Materials." Wiley.
  77. NIOSH. 2024. "Pocket Guide to Chemical Hazards." U.S. Department of Health and Human Services. https://www.cdc.gov/niosh/npg/.
  78. United Nations Economic Commission for Europe (UNECE). 2023. "European Agreement concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." UNECE. https://unece.org/transport/standards/transport/dangerous-goods/adr-2025.
  79. IPCS INCHEM. 2024. "International Programme on Chemical Safety — Waste Management Guidelines." WHO/UNEP/ILO. https://www.inchem.org/.
  80. International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories." ISO. https://www.iso.org/standard/66912.html.
  81. World Health Organization. 2010. "WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (WHO Technical Report Series No. 957, Annex 3)." WHO Press. https://www.who.int/publications/m/item/trs957-annex3.
  82. European Medicines Agency. 2014. "Guideline on Process Validation for Finished Products — Information and Data to Be Provided EMA/CHMP/CVMP/QWP/BWP/70278/2012." European Medicines Agency. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-process-validation-finished-products-information-data-be-provided-regulatory-submissions-revision-1_en.pdf.
  83. United States Pharmacopeial Convention. 2024. "United States Pharmacopeia and National Formulary, USP 47-NF 42." USP. https://www.uspnf.com/.
  84. European Pharmacopoeia Commission. 2024. "European Pharmacopoeia 11th Edition." Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
  85. Pharmaceutical Inspection Co-operation Scheme (PIC/S). 2021. "Guide to Good Manufacturing Practice for Medicinal Products PE 009-15." PIC/S Secretariat, Geneva. https://picscheme.org/en/publications.
  86. International Pharmaceutical Excipients Council (IPEC) and Pharmaceutical Quality Group (PQG). 2017. "Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients." IPEC-Americas. https://ipecamericas.org/sites/default/files/IPECPQGGMPGuide2017.pdf.
📥 下载BibTeX📥 下载RIS导入到Zotero/Mendeley/EndNote/Papers。